<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 /home/lopez/grobid/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Indoleamine 2,3-dioxygenase activity and clinical outcome following induction chemotherapy and concurrent chemoradiation in Stage III non-small cell lung cancer</title>
			</titleStmt>
			<publicationStmt>
				<publisher>Informa UK Limited</publisher>
				<availability status="unknown"><p>Copyright Informa UK Limited</p>
				</availability>
				<date type="published" when="2013-03">2013-03</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author role="corresp">
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ben</forename><forename type="middle">C</forename><surname>Creelan</surname></persName>
							<email>creelan@gmail.com</email>
							<affiliation key="aff0">
								<orgName type="institution">University of south Florida</orgName>
								<address>
									<settlement>Tampa</settlement>
									<country>FL Usa</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Scott</forename><forename type="middle">J</forename><surname>Antonia</surname></persName>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Gerold</forename><surname>Bepler</surname></persName>
							<affiliation key="aff2">
								<orgName type="institution" key="instit1">Karmanos cancer Institute</orgName>
								<orgName type="institution" key="instit2">Wayne state University</orgName>
								<address>
									<settlement>Detroit</settlement>
									<region>MI</region>
									<country key="US">Usa</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Timothy</forename><forename type="middle">J</forename><surname>Garrett</surname></persName>
							<affiliation key="aff3">
								<orgName type="institution">University of Florida</orgName>
								<address>
									<addrLine>5 MD anderson cancer center; houston</addrLine>
									<settlement>Gainesville</settlement>
									<region>TX</region>
									<country>FL Usa, Usa</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">George</forename><forename type="middle">R</forename><surname>Simon</surname></persName>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hatem</forename><forename type="middle">H</forename><surname>Soliman</surname></persName>
							<affiliation key="aff1">
								<address>
									<addrLine>Lee Moffitt cancer center</addrLine>
									<settlement>Tampa</settlement>
									<region>FL</region>
									<country key="US">Usa</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Indoleamine 2,3-dioxygenase activity and clinical outcome following induction chemotherapy and concurrent chemoradiation in Stage III non-small cell lung cancer</title>
					</analytic>
					<monogr>
						<title level="j" type="main">OncoImmunology</title>
						<title level="j" type="abbrev">OncoImmunology</title>
						<idno type="eISSN">2162-402X</idno>
						<imprint>
							<publisher>Informa UK Limited</publisher>
							<biblScope unit="volume">2</biblScope>
							<biblScope unit="issue">3</biblScope>
							<biblScope unit="page">e23428</biblScope>
							<date type="published" when="2013-03" />
						</imprint>
					</monogr>
					<idno type="DOI">10.4161/onci.23428</idno>
					<idno type="PMID">23802083</idno>
					<idno type="PMCID">PMC3661168</idno>
					<ptr type="open-access" target="https://www.tandfonline.com/doi/pdf/10.4161/onci.23428?needAccess=true" />
					<note type="submission">Submitted: 09/11/12; Revised: 12/26/12; Accepted: 12/28/12</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.6.2-SNAPSHOT" ident="GROBID" when="2020-08-14T00:00+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>indoleamine 2,3 dioxygenase, innate immunity, kynurenine, non-small cell lung cancer, tryptophan AJCC, American joint committee on cancer</term>
					<term>AUC, area under the curve</term>
					<term>BIN1, bridging integrator 1</term>
					<term>CI, confidence interval</term>
					<term>CT, computed tomography</term>
					<term>CTLA-4, cytotoxic T-lymphocyte antigen 4</term>
					<term>D-1MT, 1-methyl-D-tryptophan</term>
					<term>ECOG, Eastern Cooperative Oncology Group</term>
					<term>GCN-2, general control nonrepressed 2</term>
					<term>HPLC, high performance liquid chromatography</term>
					<term>HR, hazard ratio</term>
					<term>IDO, indoleamine 2,3 dioxygenase</term>
					<term>IFN, interferon</term>
					<term>IHC, immunohistochemistry</term>
					<term>ILT, immunoglobulin-like transcript</term>
					<term>IPMN, intraductal papillary mucinous neoplasm</term>
					<term>Kyn, kynurenine</term>
					<term>MS, mass spectrometry</term>
					<term>mTOR, mammalian target of rapamycin</term>
					<term>NCT, national clinical trial</term>
					<term>NSCLC, non-small cell lung cancer</term>
					<term>OS, overall survival</term>
					<term>PET, positron emission tomography</term>
					<term>PFS, progression-free survival</term>
					<term>PKCΘ, protein kinase C Θ</term>
					<term>RECIST, response evaluation criteria in solid tumors</term>
					<term>STAT1, signal transducer and activator of transcription 1</term>
					<term>TGF, transforming growth factor</term>
					<term>TIL, tumor-infiltrating lymphocyte</term>
					<term>Trp, tryptophan</term>
				</keywords>
			</textClass>
			<abstract/>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Introduction</head><p>Indoleamine 2,3-dioxygenase (IDO) is a cytosolic protein that catalyzes the rate-limiting step of human tryptophan (Trp) metabolism. Trp depletion induces effector T cells to undergo a G 1 cell cycle arrest <ref type="bibr" target="#b0">1</ref> and triggers an integrated stress response pathway that involves general control nonrepressed 2 (GCN2) signaling and eukaryotic initiation factor 2α (eIF2α) phosphorylation. <ref type="bibr" target="#b1">2,</ref><ref type="bibr" target="#b2">3</ref> IDO also causes systemic anergy by inducing naive Indoleamine 2,3-dioxygenase (IDO) has recently been proposed to account for tumor-induced immunosuppression by influencing the conversion of tryptophan (Trp) into kynurenine (Kyn). The objective of our study was to correlate IDO activity with disease outcome in non-small cell lung cancer (NscLc) patients treated with multimodal combination therapy. In a single-arm phase II trial involving induction gemcitabine and carboplatin followed by concurrent paclitaxel, carboplatin and 74 Gy thoracic radiation in stage III NscLc patients, plasma was drawn at baseline, post-induction, and post-concurrent therapy. The mean plasma Kyn/Trp ratio was used as a surrogate indicator of IDO activity. The 33 participants were distributed as follows: 15 females, 18 males; median age = 62; median overall survival (Os) = 22.4 (95% cI 19.3-25.1) months; median progression-free survival (pFs) = 11.5 (95% cI 6.7-16.3) months. The mean Kyn/Trp ratio at baseline (4.5 ± 2.8) was higher than that of healthy controls (2.9 ± 1.9, p = 0.03) and increased after induction therapy (5.2 ± 3.2, p = 0.08) and chemoradiation (5.8 ± 3.9, p = 0.01). The post-treatment Kyn/Trp ratio and radiologic responses were not significantly associated at any time point. No significant correlation was found between baseline Kyn/Trp ratios and Os (hR = 1.1, 95% cI 0.45-2.5) or pFs (hR = 0.74, 95% cI 0.30-1.82). a post-induction chemotherapy increase in IDO activity portended worse Os (hR = 0.43, 95% cI 0.19-0.95, p = 0.037) and pFs (hR = 0.47, 95% cI 0.22-1.0, p = 0.055). This observed increase in IDO transcription may be a means for tumors to evade immunosurveillance.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Indoleamine 2,3-dioxygenase activity and clinical outcome following induction chemotherapy and concurrent chemoradiation in Stage III non-small cell lung cancer</head><p>T cells to differentiate into CD4 + CD25 + FOXP3 + regulatory T cells. <ref type="bibr" target="#b3">4</ref> Dendritic cells respond to low Trp levels by upregulating inhibitory factors such as immunoglobulin-like transcript 3 (ILT3), ILT4 and transforming growth factor β1 (TGF-β1), thus becoming immunosuppressive. <ref type="bibr" target="#b4">5</ref> Moreover, Trp metabolites such as kynurenine (Kyn), quinolinic acid, and picolinic acid exert cytotoxic effects on CD8 + tumor-infiltrating lymphocytes (TILs) and CD4 + T H 1 cells. <ref type="bibr" target="#b6">6,</ref><ref type="bibr" target="#b7">7</ref> The IDO-mediated deprivation of Trp also inhibits the immunomodulatory kinases mammalian target anticancer vaccines. <ref type="bibr" target="#b14">11,</ref><ref type="bibr" target="#b53">12</ref> Cancer cells bearing mutations in the oncosuppressor gene BIN1 are stimulated by interferon γ (IFNγ) to overexpress IDO, leading to increased intracellular levels of signal transducer and activator of transcription 1 (STAT1) and nuclear factor κB (NFκB). <ref type="bibr" target="#b55">13</ref> Thus, IDO may be an important stimulator of immune tolerance in human cancer. Non-small cell lung cancer (NSCLC) is an aggressive epithelial malignancy that often overexpresses the mRNA coding for IDO. 14 NSCLC has an annual incidence of 1.61 million people worldwide, <ref type="bibr" target="#b57">15,</ref><ref type="bibr">16</ref> and 83 percent of NSCLC patients will eventually die of their cancer. <ref type="bibr">16</ref> Locoregionally-advanced NSCLC comprises more than one-third of cases at presentation and is classified as Stage III. <ref type="bibr" target="#b59">17</ref> Over three quarters of Stage III NSCLC patients are technically or medically inoperable. <ref type="bibr" target="#b61">18</ref> Chemotherapy and concurrent radiation is the standard therapy for inoperable Stage III NSCLC, but the five year overall survival (OS) remains poor, that is, 20% and 8% for IIIA and IIIB disease, respectively. <ref type="bibr" target="#b64">19</ref> Such an aggressive malignant phenotype has been hypothesized to stem from an innate resistance of NSCLC to chemotherapy <ref type="bibr" target="#b66">20,</ref><ref type="bibr" target="#b67">21</ref> and to its ability to evade immunosurveillance. <ref type="bibr" target="#b69">22,</ref><ref type="bibr" target="#b70">23</ref> However, the role of IDO in mediating immune tolerance in NSCLC is unclear.</p><p>Trp catabolism in lung cancer patients is associated with advanced disease stage. <ref type="bibr" target="#b71">24,</ref><ref type="bibr" target="#b73">25</ref> This said, how IDO activity changes of rapamycin (mTOR) and protein kinase C Θ (PKCΘ), thereby inhibiting autophagy. <ref type="bibr" target="#b9">8</ref> In fact, IDO is overexpressed by many human cancers <ref type="bibr" target="#b11">9</ref> and may serve as an escape mechanism from host immunity. <ref type="bibr" target="#b12">10</ref> For example, in humans and animals, the induction of IDO limits the immune response to dendritic cell-based  ratios at Time 2, with p = 0.19 ( <ref type="figure" target="#fig_3">Fig. 4B)</ref>. To index the shift in IDO activity after chemotherapy, the differences in Kyn/Trp ratios between Time 0 and Time 1 (ΔIDO 1 ) and between Time 1 and Time 2 (ΔIDO 2 ) were calculated. Participants were subdivided into two groups based on the median ΔIDO value. Using RECIST to define the percentage of response, a non-significant trend was observed between radiologic responses at Time 1 and ΔIDO 1 <ref type="figure" target="#fig_4">(Fig. 5)</ref>.</p><p>Median OS was 22.4 mo (95% CI 19.3-25.1) and median progression-free survival (PFS) 11.5 mo (95% CI 6.7-16.3) ( <ref type="table" target="#tab_1">Table 2)</ref>.</p><p>after chemotherapy or radiation in NSCLC patients is unclear. The abrogation of BIN1 causes IDO overexpression and promotes NSCLC in animals. <ref type="bibr" target="#b74">26</ref> NSCLC-infiltrating lymphocytes are often anergic and hypoproliferative, <ref type="bibr" target="#b36">27</ref> and the overexpression of IDO in the NSCLC peritumoral stroma is associated with poor prognosis. <ref type="bibr" target="#b37">28</ref> Based on the these observations, we hypothesized that IDO activity may increase in Stage III NSCLC patients undergoing conventional multimodal therapy. Since Kyn is the primary metabolite of Trp metabolism, the plasma Kyn/Trp ratio has been used as a surrogate indicator of IDO activity. <ref type="bibr" target="#b38">29,</ref><ref type="bibr" target="#b39">30</ref> Our objective was to prospectively correlate serial changes in IDO activity, as measured by the plasma Kyn/Trp ratio, with radiologic response and survival in NSCLC patients treated with multimodal therapy.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head><p>Forty-three participants were enrolled from December 2003 to February 2006. Of 39 participants initiated on treatment, 33 had plasma drawn at Time 0 evaluable for mass spectrometry <ref type="figure" target="#fig_0">(Fig. 1)</ref>. We observed no trends between baseline plasma metabolites and demographic features such as age, race, gender, and performance status ( <ref type="table" target="#tab_0">Table 1)</ref>. Moreover, we observed no correlations between baseline plasma markers and tumor characteristics such as histology or clinical stage. However, these correlative studies were limited by a relatively low statistical power. To assess the presence of outliers, we used a formal outlier test, the extreme studentized deviate (ESD) method with p &lt; 0.05, which identified one outlier at time 0 (14.5 with z = 3.6) and no outliers at Time 1 and Time 2. To further assess the influence of outliers, we examined the clinicopathologic features of the six participants displaying the highest Kyn/Trp ratio at Time 0 and Time 1 compared with the rest the cohort. No statistically significant differences in age, survival, tumor burden, chemotherapy response, white blood count and serum albumin was observed.</p><p>Compared with a sample of 24 healthy controls (2.9 ± 1.9), participants had higher mean Kyn/Trp ratio at baseline (4.5 ± 2.8, p = 0.03) ( <ref type="figure" target="#fig_1">Fig. 2)</ref>. Mean plasma Kyn/Trp ratios increased after induction chemotherapy (Time 0 to Time 1, 5.2 ± 3.2, p = 0.08), and after concurrent definitive chemoradiation (Time 1 to Time 2, 5.8 ± 3.9, p = 0.01). No correlation was observed between baseline plasma Kyn/Trp ratios and primary tumor cross-sectional area (r = 0.10, 95% CI −0.27-0.43) or total crosssectional area of all target lesions on CT (CT) (r = 0.02, 95% CI −0.33-0.37) <ref type="figure" target="#fig_2">(Fig. 3A)</ref>. Likewise, no appreciable correlation was observed between changes in plasma Kyn/Trp ratios from Time 0 to Time 1 (ΔIDO 1 ) and changes in primary tumor crosssectional area (r = -0.25, 95% CI −0.56-0.12) or changes in total cross-sectional area of all target lesions on CT (r = −0.17, 95% CI −0.50-0.20) <ref type="figure" target="#fig_2">(Fig. 3B)</ref>.</p><p>After induction chemotherapy, we observed one complete response, 11 partial responses and 21 patients with stable disease. Using response evaluation criteria in solid tumors (RECIST), a non-statistically significant association was observed between improved radiologic responses and plasma Kyn/Trp ratios at Time 1, with p = 0.34 ( <ref type="figure" target="#fig_3">Fig. 4A)</ref>. A similar non-significant trend was observed between radiologic responses and plasma Kyn/Trp carcinoma, melanoma, 32 colorectal carcinoma, <ref type="bibr" target="#b44">33</ref> esophageal cancer, <ref type="bibr" target="#b45">34,</ref><ref type="bibr" target="#b46">35</ref> thyroid carcinoma, <ref type="bibr" target="#b47">36</ref> acute myelogenous leukemia, <ref type="bibr" target="#b48">37</ref> breast cancer <ref type="bibr" target="#b50">38</ref> and gynecologic cancer <ref type="bibr" target="#b38">29</ref> patients. This observation lends credence to the hypothesis that cancer cells may stimulate dendritic cells to express IDO or may directly overexpress the enzyme. Indeed, NSCLCs exhibit high Trp metabolism as monitored by α-methyl-tryptophan positron emission tomography (PET) imaging as compared with normal tissues. <ref type="bibr" target="#b51">39</ref> We could not observe a strong correlation between baseline tumor sizes and Kyn/Trp ratios, or a strong correlation between changes in tumor size and changes in Kyn/Trp ratios. This suggests that Kyn/Trp ratios are unlikely to be determined by the tumor burden alone.</p><p>Consistent with previous observations in NSCLC patients, <ref type="bibr" target="#b71">24</ref> we did not find a correlation between baseline IDO activity and survival. Several authors have examined the relationship between IDO activity and survival in other cancers ( <ref type="table" target="#tab_2">Table 3)</ref>. Of interest, studies based on the immunohistochemical detection of IDO more often reported an unfavorable role for IDO than studies based on the detection of IDO mRNA levels (16:1 vs 1:6, Baseline Kyn/Trp ratios were not significantly associated with OS (HR = 0.88, 95% CI 0.41-1.35). After induction chemotherapy at Time 1, patients with high ΔIDO 1 had worse OS (p = 0.037) and a trend toward worse PFS (p = 0.055) as compared with individuals with low ΔIDO 1 <ref type="figure" target="#fig_5">(Fig. 6)</ref>. However, no association was found after chemoradiation between ΔIDO 2 and OS (HR = 1.1, 95% CI 0.45-2.5) or PFS (HR = 0.74, 95% CI 0.30-1.82).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p>To our knowledge, this is the first report to serially explore changes in plasma IDO activity during the treatment of Stage III NSCLC patients, as measured by Kyn/Trp ratios. We found that IDO activity was higher in cancer patients than in healthy individuals, consistent with previous observations in lung cancer, <ref type="bibr" target="#b71">24,</ref><ref type="bibr" target="#b73">25,</ref><ref type="bibr" target="#b41">31</ref> bladder cancer, hepatocellular carcinoma, renal cell   Fischer's exact p = 0.0003). This difference may reflect a posttranscriptional regulation of IDO. Our study also examined the relationship between changes in IDO activity and disease outcome. Our results suggest that a high increase in IDO activity after chemotherapy is associated with a higher risk of mortality. A possible explanation for our findings is that the expression of IDO by tumor cells may mediate-at least in part-resistance to chemotherapy. <ref type="bibr" target="#b52">40</ref> Along these lines, it has recently been reported that a subset of NSCLC patients with favorable radiologic responses after chemotherapy exhibit a significant decrease in IDO activity within monocytes as compared with baseline conditions. <ref type="bibr" target="#b15">41</ref> Tumors may generate a hostile microenvironment that impedes host antitumor immune response. Interestingly, no changes in the expression of IDO by tumor cells was observed in melanoma biopsies at baseline and during regression in response to tremelimumab treatment, <ref type="bibr" target="#b17">42</ref> suggesting that IDO activity may not be influenced by cytotoxic T-lymphocyte antigen 4 (CTLA-4) inhibition. Several aspects of our report necessitate a more detailed investigation before firm conclusions can be drawn. Due to a small sample size, our trial was statistically underpowered to detect any significant association between Kyn/Trp ratios and demographic characteristics. Likewise, our patient sample was too small to establish a stepwise dose-effect relationship between IDO activity and clinical outcome. Next, tissues were not available for the immunohistochemical detection of IDO, so we used plasma Kyn/Trp ratios as a convenient surrogate marker for IDO activity. Other studies have used plasma Kyn/Trp ratios as an indirect measure for IDO activity ( <ref type="table" target="#tab_2">Table 3</ref>) and these correlate well with immunohistochemical data. <ref type="bibr" target="#b18">43</ref> However, plasma Kyn/Trp ratios are not a direct measure of IDO activity. In particular, other Trp catabolizing enzymes, including tryptophan 2,3-dioxygenase and the IDO splice variant known as IDO2 contribute to Kyn production as well. Moreover, our study did not mandate uniform timing for blood draws. Since plasma Trp levels may vary by as much as 20% in the same subject depending on the distance of the last meal and the diurnal cycle, <ref type="bibr" target="#b19">44</ref> we acknowledge this as a potential confounder. Nonetheless, plasma Kyn has only minor diurnal variation, <ref type="bibr" target="#b18">43</ref> and the changes that we observed in Kyn/Trp ratios appeared predominantly attributable to Kyn <ref type="figure" target="#fig_1">(Fig. 2)</ref>. Another drawback of the present study is that correlative immunologic markers, such as FOXP3 expression, CD3 activity, and IFN production were not measured. Additional markers may help to substantiate the putative role of IDO in this patient population. Moreover, conclusions cannot be drawn about the effect of individual chemotherapy agents, which are known to have specific immunomodulatory properties. <ref type="bibr" target="#b20">45,</ref><ref type="bibr" target="#b22">46</ref> Finally, our calculations were performed without multiple comparison rules. <ref type="bibr" target="#b24">47</ref> Thus, the possibility exists that the observed associations could stem from family-wise errors. In view of all these limitations, our results should be strictly viewed as exploratory.</p><p>In summary, our findings may serve as a rationale for larger studies correlating changes in the Kyn/Trp ratio with clinical parameters during standard multimodal therapy against NSCLC. As IDO may contribute to the resistance of NSCLC to therapy, this clinical setting may be a fertile area for the investigation of the antineoplastic effects of IDO inhibitors, such as1-methyl-D-tryptophan (D-1MT). <ref type="bibr" target="#b25">48</ref> </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Materials and Methods</head><p>Patients. The design of the clinical trial has been previously described. <ref type="bibr" target="#b27">49</ref> Briefly, our single-arm trial used induction gemcitabine (1 g/m 2 ) on day 1 and day 8 and carboplatin (AUC = 5) on day 1 given at 4-week intervals for two cycles. This was followed by weekly carboplatin (AUC = 2) and paclitaxel (50 mg/m 2 ) with concurrent conformal radiation (dose = 74 Gy ± 5%) administered over 40 daily fractions. Plasma was collected at baseline (Time 0), after induction at week 9 (Time 1), and after  individual mean concentrations were recorded. The intraassay and day-to-day analytic coefficients of variation were less than 5% for each analyte <ref type="table" target="#tab_0">(Table S1)</ref>. Statistics. The plasma concentrations of Kyn and Trp, as well as Kyn/Trp ratios approximated a parametric distribution. Therefore, data were presented as means ± SD. Due to the small sample size, the associations between serum biomarker levels and clinicopathologic variables were evaluated with Wilcoxon ranksum and Kruskal-Wallis tests. Wilcoxon signed rank was used to compare between time points. Correlation was estimated using Spearman's rho. Survival curves were calculated according to the Kaplan-Meier method. To address the experimental hypothesis, the statistical population was equally divided into "hig" and "low" patients using the median Kyn/Trp value as pre-specified cut-point. The effects of biomarkers on PFS and OS were evaluated using log-rank (Mantel-Cox) test and Cox proportionalhazards regression models. All tests performed were two-tailed. Statistical analysis was performed using the SAS software (version 8.0). Figures and survival plots were generated using GraphPad Prism ® (version 5.04).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Disclosure of Potential Conflicts of Interest</head><p>The authors have no conflicts of interest to disclose.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Supplemental Material</head><p>Supplemental materials may be found here: http://www.landesbioscience.com/journals/oncoimmunology/ article/23428/ evaluated all scans. OS was defined as the interval between the date of treatment and the date of death. PFS was defined as the interval between the date of treatment and the date of progression or death from any cause. Participants without an event were censored as of the date of last follow-up, which occurred between August and September 2009.</p><p>All procedures were approved by the Institution Review Board (IRB) from the University of South Florida (FWA00001669) and were in accordance with the Helsinki Declaration of 1975. Participants prospectively provided informed consent for the use of their tissue in research.</p><p>Measurement of plasma markers. Heparinized blood samples were drawn and centrifuged at 800 g for 10 min to extract plasma and then stored at −80°C. HPLC/MS/MS was performed with gradient elution on a C18 column (Thermo Betabasic, 150 mm × 2.1 mm, 5 μm particles) with matching guard column at a flow rate of 500 μL/min using heated electrospray ionization in the positive ion mode. <ref type="bibr" target="#b29">50</ref> Gradient solvents were 0.1% formic acid in water and acetonitrile with 0.1% formic acid (HPLC grade, Fisher-Scientific). The mass spectrometer (TSQ Quantum Ultra, Thermo) was operated in selected reaction monitoring mode (SRM). Calibration standards for Trp and Kyn (Fisher-Scientific) were prepared in albumin (Sigma) in the ranges of 10-2,000 ng/mL for Kyn and 100-20,000 ng/mL for Trp. Quality control samples were prepared in albumin at 10, 100, 1000 ng/mL for Kyn and 100, 1,000, 10,000 ng/mL for Trp. 150 μL of internal standard solution containing Trp-d3 at 4,000 ng/mL and Kyn-d6 at 400 ng/mL (Cambridge Isotopes) were added and mixed to 150 μL of calibration standard, quality control, and clinical specimens. For protein precipitation, 30 μL of 2.4 M perchloric acid (Fisher-Scientific) were added, samples were vortexed and cooled for 5 min, then centrifuged at 20,400 g for 20 min. The supernatant was transferred to a filter tube (0.44 μm) and re-centrifuged. The filtered sample was transferred to a glass vial with 400 μL insert and 10 μL was injected onto the column. Each sample was performed in triplicate, and</p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Figure 1 .</head><label>1</label><figDesc>Trial flow diagram. Induction chemotherapy: gemcitabine and carboplatin. Thoracic radiation: 74 Gy conformal. concurrent chemotherapy: paclitaxel and carboplatin.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Figure 2 .</head><label>2</label><figDesc>plasma metabolites in stage III non-small cell lung cancer patients. (A) plasma kynurenine (Kyn) concentration. (B) plasma tryptophan (Trp) concentration. (C) plasma Kyn/Trp ratios, a surrogate for indoleamine 2,3 dioxygenase (IDO) activity. plasma IDO activity was higher in non-small cell lung cancer (NscLc) patients at baseline (Time 0) than in healthy individuals. plasma IDO activity increased after induction carboplatin/gemcitabine (Time 1) and after concurrent carboplatin/paclitaxel with thoracic radiation (Time 2). Bars: Median with interquartile range. For healthy individuals vs. Time 0: Wilcoxon rank-sum test. For Time 0 vs. Time 1 and Time 1 vs. Time 2: Wilcoxon signed-rank test. ‡ p &lt; 0.10; *p &lt; 0.05; † † p &lt; 0.01.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Figure 3 .</head><label>3</label><figDesc>correlation between tumor burden and indoleamine 2,3 dioxygenase activity. (A) correlation between cross-sectional tumor burden and plasma kynurenine/tryptophan (Kyn/Trp) ratio. n = 33, r = 0.02 (95% cI −0.33-0.37). (B) correlation between changes in cross-sectional tumor burden and changes in plasma Kyn/Trp ratios after induction carboplatin/gemcitabine (Time 1 − Time 0). n = 32, r = −0.17 (95% cI −0.50-0.20). Total burden represents the sum of cross-sectional areas for primary tumor and all target lymph nodes. cross-sectional area represents the product of the longest tumor diameter and its perpendicular axis. r = spearman's rank correlation coefficient.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>Figure 4 .</head><label>4</label><figDesc>Radiologic response and plasma kynurenine/tryptophan ratio after induction therapy (Time 1) and after concurrent carboplatin/ paclitaxel therapy coupled to thoracic radiation (Time 2). Bars: median, interquartile range. n.s. = non significant (Wilcoxon rank-sum). cR, complete response; pD, progressive disease; pR, partial response; sD, stable disease.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head>Figure 5 .</head><label>5</label><figDesc>Waterfall plot of response after induction chemotherapy. participants with reduced surges in indoleamine 2,3 dioxygenase (IDO) activity after induction chemotherapy (ΔIDO 1 ) had non-significant trend toward improved radiologic responses. The median difference in the kynurenine/ tryptophan (Kyn/Trp) ratio was taken as pre-specified cut-point. evaluable patients, n = 32; non-evaluable patients, n = 1.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_5"><head>Figure 6 .</head><label>6</label><figDesc>Relationship between changes in indoleamine 2,3 dioxygenase activity and non-small cell lung cancer patients survival. participants with a consistent increase in indoleamine 2,3 dioxygenase (IDO) activity from baseline (Time 0) to induction chemotherapy (Time 1) had shorter overall survival (Os) and a trend toward shortened progression-free survival (pFs). Median Os = 24.6 vs. 18.0 mo, hR = 0.43 (95% cI 0.19-0.95), *p = 0.037 (Log-rank test) Median pFs: 15.2 vs. 9.4 mo, hR = 0.47 (95% cI 0.22-1.02), *p = 0.055 (Log-rank test). Median difference in kynurenine/tryptophan (Kyn/Trp) (ΔIDO 1 ) was taken as pre-specified cut-point.concurrent therapy at week 25-26 (Time 2). All participants enrolled had previously untreated clinical Stage IIIA or "dry" IIIB NSCLC, as determined by American Joint Committee on Cancer (AJCC) criteria v. 6. None of these patients had received previous chemotherapy or radiation. All participants had measurable disease by RECIST v. 1.0 criteria. Both CT and PET scans were performed at Time 0, Time 1 and Time 2. Radiographic responses were quantified by the percentage of changes in the sum of all greatest tumor diameters between post-and pre-treatment scans. Institutional radiologists</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1 .</head><label>1</label><figDesc>Demographics and baseline measurements</figDesc><table><row><cell>Characteristics</cell><cell>Patients n (%)</cell><cell>Kyn (μM) Mean ± SD</cell><cell>Trp (μM) Mean ± SD</cell><cell>Kyn/Trp (μM/μM) Mean ± SD</cell></row><row><cell>Total</cell><cell>33</cell><cell>1.6 ± 0.8</cell><cell>37.9 ± 8.5</cell><cell>4.5 ± 2.8</cell></row><row><cell>Age in years (Median ± sD)</cell><cell>62.4 ± 7.9</cell><cell></cell><cell></cell><cell></cell></row><row><cell>age &lt; 65 y</cell><cell>19 (58)</cell><cell>1.6 ± 0.9</cell><cell>40.3 ± 8.2</cell><cell>4.0 ± 2.3</cell></row><row><cell>age 65 y</cell><cell>14 (42)</cell><cell>1.6 ± 0.7</cell><cell>34.7 ± 8.1</cell><cell>5.1 ± 3.3</cell></row><row><cell>Race</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>caucasian</cell><cell>31 (94)</cell><cell>1.6 ± 0.8</cell><cell>37.9 ± 8.8</cell><cell>4.6 ± 2.8</cell></row><row><cell>asian</cell><cell>1 (3)</cell><cell>0.9</cell><cell>36.5</cell><cell>2.5</cell></row><row><cell>Black</cell><cell>1 (3)</cell><cell>1.1</cell><cell>37.9</cell><cell>2.9</cell></row><row><cell>Gender</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Female</cell><cell>15 (45)</cell><cell>1.6 ± 0.8</cell><cell>36.3 ± 8.0</cell><cell>4.9 ± 2.3</cell></row><row><cell>Male</cell><cell>18 (55)</cell><cell>1.5 ± 0.8</cell><cell>38.9 ± 8.9</cell><cell>4.2 ± 1.9</cell></row><row><cell>ECOG* performance status</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>ps 0</cell><cell>11 (33)</cell><cell>1.5 ± 1.0</cell><cell>37.4 ± 10.7</cell><cell>5.5 ± 2.3</cell></row><row><cell>ps 1</cell><cell>22 (66)</cell><cell>1.6 ± 0.7</cell><cell>38.0 ± 8.0</cell><cell>4.6 ± 1.6</cell></row><row><cell>Smoking status</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>active smoker</cell><cell>12 (36)</cell><cell>1.7 ± 0.8</cell><cell>38.6 ± 7.7</cell><cell>4.5 ± 3.1</cell></row><row><cell>Former smoker</cell><cell>21 (64)</cell><cell>1.5 ± 0.8</cell><cell>37.4 ± 9.3</cell><cell>4.4 ± 2.3</cell></row><row><cell>AJCC  § clinical stage</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>IIIa</cell><cell>16 (48)</cell><cell>1.6 ± 0.9</cell><cell>38.2 ± 9.2</cell><cell>4.7 ± 2.7</cell></row><row><cell>IIIB</cell><cell>17 (52)</cell><cell>1.6 ± 0.7</cell><cell>37.5 ± 8.0</cell><cell>4.3 ± 2.2</cell></row><row><cell>Histotype of NSCLC</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>adenocarcinoma</cell><cell>11 (33)</cell><cell>1.5 ± 0.7</cell><cell>37.4 ± 7.2</cell><cell>4.0 ± 1.3</cell></row><row><cell>squamous cell</cell><cell>10 (30)</cell><cell>1.4 ± 0.8</cell><cell>39.7 ± 7.4</cell><cell>3.8 ± 3.3</cell></row><row><cell>Other  ‡</cell><cell>12 (36)</cell><cell>1.8 ± 0.8</cell><cell>36.9 ± 10.7</cell><cell>5.3 ± 2.3</cell></row></table><note>*eastern cooperative Oncology Group.§ american Joint committee on cancer.‡ Includes bronchoalveolar, large cell and "not otherwise specified." No statistically significant mean difference was detected for any comparison of the groups presented (p &lt; 0.05, Wilcoxon rank-sum test).</note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 2 .</head><label>2</label><figDesc>summary of results</figDesc><table><row><cell>Characteristics</cell><cell>Time 0</cell><cell>Time 1</cell><cell>Time 2</cell></row><row><cell>N</cell><cell>33</cell><cell>32</cell><cell>27</cell></row><row><cell>Analytes (mean ± sD)</cell><cell></cell><cell></cell><cell></cell></row><row><cell>Kyn (μM)</cell><cell>1.59 ± 0.77</cell><cell>1.58 ± 0.73</cell><cell>2.05 ± 1.25</cell></row><row><cell>Trp (μM)</cell><cell>37.9 ± 8.5</cell><cell>34.1 ± 8.7</cell><cell>35.2 ± 6.7</cell></row><row><cell>Kyn/Trp (μM/μM)</cell><cell>4.5 ± 2.8</cell><cell>5.15 ± 3.12</cell><cell>6.11 ± 4.02</cell></row><row><cell>Radiology</cell><cell></cell><cell></cell><cell></cell></row><row><cell>primary tumor area (cm 2 )</cell><cell>18.7 ± 17.9</cell><cell>11.0 ± 10.4</cell><cell>5.5 ± 4.7</cell></row><row><cell>Total tumor area (cm 2 )</cell><cell>27.6 ± 19.2</cell><cell>16.1 ± 12.0</cell><cell>7.4 ± 5.5</cell></row><row><cell>Survival</cell><cell>Median</cell><cell>95% CI</cell><cell>Events</cell></row><row><cell>pFs (mo)</cell><cell>11.5</cell><cell>(6.7-16.3)</cell><cell>29/33</cell></row><row><cell>Os (mo)</cell><cell>22.2</cell><cell>(19.2-25.1)</cell><cell>27/33</cell></row></table><note>pFs, progression-free survival; Os, overall survival; cI, confidence inter- val; sD, standard deviation; Mo, months.</note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head>Table 3 .</head><label>3</label><figDesc>select studies of indoleamine 2,3 dioxygenase IDO in human cancers</figDesc><table><row><cell>Neoplasm type</cell><cell>Stage</cell><cell>Tissue source</cell><cell>Sample size (n) for survival</cell><cell>Prognostic for survival</cell><cell>Reference</cell></row><row><cell>Lung</cell><cell>all</cell><cell>serum kyn/trp</cell><cell>123</cell><cell>Null</cell><cell>24</cell></row><row><cell>Breast</cell><cell>I-III</cell><cell>serum kyn/trp</cell><cell>33</cell><cell>n/a</cell><cell>38</cell></row><row><cell>Ovarian, serous</cell><cell>III-IV</cell><cell>Tumor Ihc</cell><cell>24</cell><cell>Unfavorable</cell><cell>40</cell></row><row><cell>Ovarian, epithelial</cell><cell>Ic-IV</cell><cell>Tumor Ihc</cell><cell>60</cell><cell>Unfavorable</cell><cell>51</cell></row><row><cell>Renal cell</cell><cell>IV</cell><cell>Tumor mRNa</cell><cell>107</cell><cell>Favorable</cell><cell>52</cell></row><row><cell>hepatocellular</cell><cell>all</cell><cell>Tumor Ihc</cell><cell>138</cell><cell>Unfavorable</cell><cell>53</cell></row><row><cell>Ovarian</cell><cell></cell><cell></cell><cell>28</cell><cell></cell><cell></cell></row><row><cell>endometrial</cell><cell>all</cell><cell>serum kyn/trp</cell><cell>41</cell><cell>n/a</cell><cell>29</cell></row><row><cell>Vulvar</cell><cell></cell><cell></cell><cell>40</cell><cell></cell><cell></cell></row><row><cell>Ovarian</cell><cell>III-IV</cell><cell>Tumor Ihc</cell><cell>122</cell><cell>Unfavorable</cell><cell>54</cell></row><row><cell>Lung</cell><cell>all</cell><cell>Tumor Ihc</cell><cell>28</cell><cell>n/a</cell><cell>14</cell></row><row><cell>Breast Breast, basal-like</cell><cell>all</cell><cell>Tumor mRNa</cell><cell>1059 209</cell><cell>Null Favorable</cell><cell>55</cell></row><row><cell>Oral squamous</cell><cell>all</cell><cell>Tumor Ihc</cell><cell>88</cell><cell>Unfavorable</cell><cell>56</cell></row><row><cell>Breast</cell><cell>all</cell><cell>Tumor mRNa</cell><cell>30</cell><cell>Null</cell><cell>57</cell></row><row><cell>colorectal</cell><cell>all</cell><cell>Tumor Ihc</cell><cell>143</cell><cell>Unfavorable</cell><cell>58</cell></row><row><cell>colorectal</cell><cell>all</cell><cell>Tumor Ihc</cell><cell>265</cell><cell>Unfavorable</cell><cell>59</cell></row><row><cell>endometrial</cell><cell>all</cell><cell>Tumor Ihc</cell><cell>80</cell><cell>Unfavorable</cell><cell>60</cell></row><row><cell>pancreatic</cell><cell>all</cell><cell>Tumor Ihc</cell><cell>17</cell><cell>n/a</cell><cell>61</cell></row><row><cell>colorectal</cell><cell>II-IV</cell><cell>Tumor Ihc</cell><cell>69</cell><cell>n/a</cell><cell>62</cell></row><row><cell>Osteosarcoma</cell><cell>all</cell><cell>Tumor Ihc</cell><cell>47</cell><cell>Unfavorable</cell><cell>63</cell></row><row><cell>esophageal, squamous</cell><cell>I-III</cell><cell>Tumor Ihc</cell><cell>45</cell><cell>n/a</cell><cell>34</cell></row><row><cell>acute myelogenous leukemia</cell><cell>all</cell><cell>Tumor mRNa</cell><cell>262</cell><cell>Unfavorable</cell><cell>37</cell></row><row><cell>Melanoma, uveal</cell><cell>-</cell><cell>Tumor Ihc</cell><cell>7</cell><cell>n/a</cell><cell>64</cell></row><row><cell>pancreatic IpMNs*</cell><cell>-</cell><cell>Tumor Ihc</cell><cell>39</cell><cell>n/a</cell><cell>65</cell></row><row><cell>endometrial</cell><cell>all</cell><cell>Tumor Ihc</cell><cell>355</cell><cell>Unfavorable</cell><cell>66</cell></row><row><cell>Vulvar</cell><cell>all</cell><cell>Tumor Ihc</cell><cell>286</cell><cell>Null</cell><cell>67</cell></row><row><cell>Melanoma</cell><cell>III</cell><cell>Tumor Ihc</cell><cell>25</cell><cell>Unfavorable</cell><cell>68</cell></row><row><cell>Melanoma</cell><cell>I-III</cell><cell>Tumor Ihc</cell><cell>26</cell><cell>n/a</cell><cell>69</cell></row><row><cell>cervical</cell><cell>n/a</cell><cell>Tumor Ihc</cell><cell>17</cell><cell>n/a</cell><cell>70</cell></row><row><cell>hepatocellular</cell><cell>all</cell><cell>Tumor mRNa</cell><cell>21</cell><cell>Favorable</cell><cell>71</cell></row><row><cell>colorectal</cell><cell>all</cell><cell>Tumor Ihc</cell><cell>71</cell><cell>Unfavorable</cell><cell>72</cell></row><row><cell>Lymphoma</cell><cell>all</cell><cell>Tumor Ihc</cell><cell>119</cell><cell>Unfavorable</cell><cell>73</cell></row><row><cell>Melanoma</cell><cell>all</cell><cell>serum kyn/trp</cell><cell>87</cell><cell>Unfavorable</cell><cell>32</cell></row><row><cell>endometrial</cell><cell>all</cell><cell>Tumor Ihc</cell><cell>65</cell><cell>Unfavorable</cell><cell>74</cell></row><row><cell>esophageal, squamous</cell><cell>all</cell><cell>Tumor mRNa</cell><cell>30</cell><cell>Unfavorable</cell><cell>35</cell></row><row><cell>cervical</cell><cell>IB-IIB</cell><cell>Tumor Ihc</cell><cell>112</cell><cell>Unfavorable</cell><cell>75</cell></row><row><cell>Thyroid</cell><cell>all</cell><cell>Tumor mRNa</cell><cell>20</cell><cell>Null</cell><cell>36</cell></row><row><cell>Melanoma</cell><cell>all</cell><cell>Tumor Ihc</cell><cell>116</cell><cell>Unfavorable</cell><cell>76</cell></row><row><cell>Lung, Non-small cell</cell><cell>n/a</cell><cell>serum kyn/trp</cell><cell>36</cell><cell>n/a</cell><cell>25</cell></row><row><cell cols="6">Favorable, improved survival with higher IDO; unfavorable, worse survival with higher IDO; null, no difference observed; n/a, not tested; Ihc, Immuno-</cell></row><row><cell cols="3">histochemistry. *Intraductal papillary mucinous neoplasm.</cell><cell></cell><cell></cell><cell></cell></row></table><note></note></figure>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgments</head><p>This work was funded by NCI R01-CA102726 and P50-CA119997, and supported in part by the NIH/NCATS Clinical and Translational Science Award to the University of Florida UL1 TR000064. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute or the National Institutes of Health.</p></div>
			</div>

			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Tryptophan deprivation sensitizes activated T cells to apoptosis prior to cell division</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Geon</forename><forename type="middle">Kook</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hyeon</forename><forename type="middle">Jin</forename><surname>Park</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Megan</forename><surname>Macleod</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Phillip</forename><surname>Chandler</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">David</forename><forename type="middle">H</forename><surname>Munn</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Andrew</forename><forename type="middle">L</forename><surname>Mellor</surname></persName>
		</author>
		<idno type="DOI">10.1046/j.1365-2567.2002.01526.x</idno>
		<idno type="PMID">12460190</idno>
		<ptr target="http://dx.doi.org/10.1046/j.1365-2567.2002.01526.x" />
	</analytic>
	<monogr>
		<title level="j">Immunology</title>
		<title level="j" type="abbrev">Immunology</title>
		<idno type="ISSN">0019-2805</idno>
		<idno type="ISSNe">1365-2567</idno>
		<imprint>
			<biblScope unit="volume">107</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="452" to="460" />
			<date type="published" when="2002-12" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">GCN2 Kinase in T Cells Mediates Proliferative Arrest and Anergy Induction in Response to Indoleamine 2,3-Dioxygenase</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">David</forename><forename type="middle">H</forename><surname>Munn</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Madhav</forename><forename type="middle">D</forename><surname>Sharma</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Babak</forename><surname>Baban</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Heather</forename><forename type="middle">P</forename><surname>Harding</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yuhong</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">David</forename><surname>Ron</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Andrew</forename><forename type="middle">L</forename><surname>Mellor</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.immuni.2005.03.013</idno>
		<idno type="PMID">15894280</idno>
		<ptr target="http://dx.doi.org/10.1016/j.immuni.2005.03.013" />
	</analytic>
	<monogr>
		<title level="j">Immunity</title>
		<title level="j" type="abbrev">Immunity</title>
		<idno type="ISSN">1074-7613</idno>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="633" to="642" />
			<date type="published" when="2005-05" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Indoleamine 2,3-dioxygenase contributes to tumor cell evasion of T cell-mediated rejection</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Maria</forename><surname>Friberg</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ronald</forename><surname>Jennings</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Marwan</forename><surname>Alsarraj</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sophie</forename><surname>Dessureault</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Alan</forename><surname>Cantor</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Martine</forename><surname>Extermann</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Andrew</forename><forename type="middle">L</forename><surname>Mellor</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">David</forename><forename type="middle">H</forename><surname>Munn</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Scott</forename><forename type="middle">J</forename><surname>Antonia</surname></persName>
		</author>
		<idno type="DOI">10.1002/ijc.10645</idno>
		<idno type="PMID">12209992</idno>
		<ptr target="http://dx.doi.org/10.1002/ijc.10645" />
	</analytic>
	<monogr>
		<title level="j">International Journal of Cancer</title>
		<title level="j" type="abbrev">Int. J. Cancer</title>
		<idno type="ISSN">0020-7136</idno>
		<idno type="ISSNe">1097-0215</idno>
		<imprint>
			<biblScope unit="volume">101</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="151" to="155" />
			<date type="published" when="2002-08-20" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">H</forename><surname>Munn</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">D</forename><surname>Sharma</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Hou</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><surname>Baban</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">R</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">J</forename><surname>Antonia</surname></persName>
		</author>
		<idno type="DOI">10.1172/jci200421583e1</idno>
		<idno type="PMID">15254595</idno>
		<ptr type="open-access" target="http://www.jci.org/articles/view/21583E1/files/pdf" />
	</analytic>
	<monogr>
		<title level="j">Journal of Clinical Investigation</title>
		<title level="j" type="abbrev">Journal of Clinical Investigation</title>
		<idno type="ISSN">0021-9738</idno>
		<imprint>
			<biblScope unit="volume">114</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="599" to="599" />
			<date type="published" when="2004-08-16" />
			<publisher>American Society for Clinical Investigation</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Tryptophan Deprivation Induces Inhibitory Receptors ILT3 and ILT4 on Dendritic Cells Favoring the Induction of Human CD4+CD25+ Foxp3+ T Regulatory Cells</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Brenk</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Scheler</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Koch</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Neumann</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">O</forename><surname>Takikawa</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Hacker</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Bieber</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Von Bubnoff</surname></persName>
		</author>
		<idno type="DOI">10.4049/jimmunol.0803277</idno>
		<idno type="PMID">19535644</idno>
		<ptr type="open-access" target="http://www.jimmunol.org/content/183/1/145.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">The Journal of Immunology</title>
		<title level="j" type="abbrev">The Journal of Immunology</title>
		<idno type="ISSN">0022-1767</idno>
		<idno type="ISSNe">1550-6606</idno>
		<imprint>
			<biblScope unit="volume">183</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="145" to="154" />
			<date type="published" when="2009-06-17" />
			<publisher>The American Association of Immunologists</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Foxp3+ T regulatory cells</title>
		<idno type="DOI">10.4049/jim-munol.0803277</idno>
		<idno type="PMID">19535644</idno>
		<ptr target="http://dx.doi.org/10.4049/jim-munol.0803277" />
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">183</biblScope>
			<biblScope unit="page" from="145" to="54" />
			<date type="published" when="2009" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Inhibition of Allogeneic T Cell Proliferation by Indoleamine 2,3-Dioxygenase–expressing Dendritic Cells</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Peter</forename><surname>Terness</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Thomas</forename><forename type="middle">M</forename><surname>Bauer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Lars</forename><surname>Röse</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Christoph</forename><surname>Dufter</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Andrea</forename><surname>Watzlik</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Helmut</forename><surname>Simon</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Gerhard</forename><surname>Opelz</surname></persName>
		</author>
		<idno type="DOI">10.1084/jem.20020052</idno>
		<idno type="PMID">12186837</idno>
		<idno type="PMCID">PMC2196057</idno>
		<ptr type="open-access" target="http://jem.rupress.org/content/196/4/447.full.pdf" />
		<ptr target="http://dx.doi.org/10.1084/jem.20020052" />
	</analytic>
	<monogr>
		<title level="j">The Journal of Experimental Medicine</title>
		<title level="j" type="abbrev">J Exp Med</title>
		<idno type="ISSN">0022-1007</idno>
		<idno type="ISSNe">1540-9538</idno>
		<imprint>
			<biblScope unit="volume">196</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="447" to="457" />
			<date type="published" when="2002-08-12" />
			<publisher>Rockefeller University Press</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Tryptophan-derived Catabolites Are Responsible for Inhibition of T and Natural Killer Cell Proliferation Induced by Indoleamine 2,3-Dioxygenase</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Guido</forename><surname>Frumento</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Rita</forename><surname>Rotondo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Michela</forename><surname>Tonetti</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Gianluca</forename><surname>Damonte</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Umberto</forename><surname>Benatti</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Giovanni</forename><forename type="middle">Battista</forename><surname>Ferrara</surname></persName>
		</author>
		<idno type="DOI">10.1084/jem.20020121</idno>
		<idno type="PMID">12186838</idno>
		<idno type="PMCID">PMC2196046</idno>
		<ptr type="open-access" target="http://jem.rupress.org/content/196/4/459.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">The Journal of Experimental Medicine</title>
		<title level="j" type="abbrev">J Exp Med</title>
		<idno type="ISSN">0022-1007</idno>
		<idno type="ISSNe">1540-9538</idno>
		<imprint>
			<biblScope unit="volume">196</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="459" to="468" />
			<date type="published" when="2002-08-12" />
			<publisher>Rockefeller University Press</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Tryptophan-derived Catabolites Are Responsible for Inhibition of T and Natural Killer Cell Proliferation Induced by Indoleamine 2,3-Dioxygenase</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Guido</forename><surname>Frumento</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Rita</forename><surname>Rotondo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Michela</forename><surname>Tonetti</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Gianluca</forename><surname>Damonte</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Umberto</forename><surname>Benatti</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Giovanni</forename><forename type="middle">Battista</forename><surname>Ferrara</surname></persName>
		</author>
		<idno type="DOI">10.1084/jem.20020121</idno>
		<idno type="PMID">12186838</idno>
		<idno type="PMCID">PMC2196046</idno>
		<ptr type="open-access" target="http://jem.rupress.org/content/196/4/459.full.pdf" />
		<ptr target="http://dx.doi.org/10.1084/jem.20020121" />
	</analytic>
	<monogr>
		<title level="j">The Journal of Experimental Medicine</title>
		<title level="j" type="abbrev">J Exp Med</title>
		<idno type="ISSN">0022-1007</idno>
		<idno type="ISSNe">1540-9538</idno>
		<imprint>
			<biblScope unit="volume">196</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="459" to="468" />
			<date type="published" when="2002-08-12" />
			<publisher>Rockefeller University Press</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">IDO inhibits a tryptophan sufficiency signal that stimulates mTOR: A novel IDO effector pathway targeted by D-1-methyl-tryptophan</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Richard</forename><surname>Metz</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sonja</forename><surname>Rust</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">James</forename><forename type="middle">B</forename><surname>Duhadaway</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mario</forename><forename type="middle">R</forename><surname>Mautino</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">David</forename><forename type="middle">H</forename><surname>Munn</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Nicholas</forename><forename type="middle">N</forename><surname>Vahanian</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Charles</forename><forename type="middle">J</forename><surname>Link</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">George</forename><forename type="middle">C</forename><surname>Prendergast</surname></persName>
		</author>
		<idno type="DOI">10.4161/onci.21716</idno>
		<idno type="PMID">23264892</idno>
		<idno type="PMCID">PMC3525601</idno>
		<ptr type="open-access" target="https://www.tandfonline.com/doi/pdf/10.4161/onci.21716?needAccess=true" />
	</analytic>
	<monogr>
		<title level="j">OncoImmunology</title>
		<title level="j" type="abbrev">OncoImmunology</title>
		<idno type="ISSNe">2162-402X</idno>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="1460" to="1468" />
			<date type="published" when="2012-12" />
			<publisher>Informa UK Limited</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">IDO inhibits a tryptophan sufficiency signal that stimulates mTOR: A novel IDO effector pathway targeted by D-1-methyl-tryptophan</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Richard</forename><surname>Metz</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sonja</forename><surname>Rust</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">James</forename><forename type="middle">B</forename><surname>Duhadaway</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mario</forename><forename type="middle">R</forename><surname>Mautino</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">David</forename><forename type="middle">H</forename><surname>Munn</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Nicholas</forename><forename type="middle">N</forename><surname>Vahanian</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Charles</forename><forename type="middle">J</forename><surname>Link</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">George</forename><forename type="middle">C</forename><surname>Prendergast</surname></persName>
		</author>
		<idno type="DOI">10.4161/onci.21716</idno>
		<idno type="PMID">23264892</idno>
		<idno type="PMCID">PMC3525601</idno>
		<ptr type="open-access" target="https://www.tandfonline.com/doi/pdf/10.4161/onci.21716?needAccess=true" />
		<ptr target="http://dx.doi.org/10.4161/onci.21716" />
	</analytic>
	<monogr>
		<title level="j">OncoImmunology</title>
		<title level="j" type="abbrev">OncoImmunology</title>
		<idno type="ISSNe">2162-402X</idno>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="1460" to="1468" />
			<date type="published" when="2012-12" />
			<publisher>Informa UK Limited</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Catherine</forename><surname>Uyttenhove</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Luc</forename><surname>Pilotte</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ivan</forename><surname>Théate</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Vincent</forename><surname>Stroobant</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Didier</forename><surname>Colau</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Nicolas</forename><surname>Parmentier</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Thierry</forename><surname>Boon</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Benoît</forename><forename type="middle">J</forename><surname>Van Den Eynde</surname></persName>
		</author>
		<idno type="DOI">10.1038/nm934</idno>
		<idno type="PMID">14502282</idno>
		<ptr target="http://dx.doi.org/10.1038/nm934" />
	</analytic>
	<monogr>
		<title level="j">Nature Medicine</title>
		<title level="j" type="abbrev">Nat Med</title>
		<idno type="ISSN">1078-8956</idno>
		<idno type="ISSNe">1546-170X</idno>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="1269" to="1274" />
			<date type="published" when="2003-09-21" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Tumor immune escape mediated by indoleamine 2,3-dioxygenase</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Maria</forename><surname>Zamanakou</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Anastasios</forename><forename type="middle">E</forename><surname>Germenis</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Vaios</forename><surname>Karanikas</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.imlet.2007.06.001</idno>
		<idno type="PMID">17644189</idno>
	</analytic>
	<monogr>
		<title level="j">Immunology Letters</title>
		<title level="j" type="abbrev">Immunology Letters</title>
		<idno type="ISSN">0165-2478</idno>
		<imprint>
			<biblScope unit="volume">111</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="69" to="75" />
			<date type="published" when="2007-08" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Tumor immune escape mediated by indoleamine 2,3-dioxygenase</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Maria</forename><surname>Zamanakou</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Anastasios</forename><forename type="middle">E</forename><surname>Germenis</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Vaios</forename><surname>Karanikas</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.imlet.2007.06.001</idno>
		<idno type="PMID">17644189</idno>
		<ptr target="http://dx.doi.org/10.1016/j.imlet.2007.06.001" />
	</analytic>
	<monogr>
		<title level="j">Immunology Letters</title>
		<title level="j" type="abbrev">Immunology Letters</title>
		<idno type="ISSN">0165-2478</idno>
		<imprint>
			<biblScope unit="volume">111</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="69" to="75" />
			<date type="published" when="2007-08" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Enhancement of dendritic cell-tumor fusion vaccine potency by indoleamine-pyrrole 2,3-dioxygenase inhibitor, 1-MT</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Xueling</forename><surname>Ou</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Shaohui</forename><surname>Cai</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Peng</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jun</forename><surname>Zeng</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yuwen</forename><surname>He</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Xinyao</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jun</forename><surname>Du</surname></persName>
		</author>
		<idno type="DOI">10.1007/s00432-007-0315-9</idno>
		<idno type="PMID">17909857</idno>
		<idno type="ark">ark:/67375/VQC-2S817D5X-0</idno>
		<idno type="istexId">4F22603139976DE965F35B53F6FA99E35BBD99DE</idno>
		<ptr target="http://dx.doi.org/10.1007/s00432-007-0315-9" />
	</analytic>
	<monogr>
		<title level="j">Journal of Cancer Research and Clinical Oncology</title>
		<title level="j" type="abbrev">J Cancer Res Clin Oncol</title>
		<idno type="ISSN">0171-5216</idno>
		<idno type="ISSNe">1432-1335</idno>
		<imprint>
			<biblScope unit="volume">134</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="525" to="533" />
			<date type="published" when="2007-10-02" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Influence of chemotherapy on nitric oxide synthase, indole-amine-2,3-dioxygenase and CD124 expression in granulocytes and monocytes of non-small cell lung cancer</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sung</forename><forename type="middle">Hoon</forename><surname>Sim</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yong-Oon</forename><surname>Ahn</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jieun</forename><surname>Yoon</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tae</forename><forename type="middle">Min</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Se-Hoon</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Dong-Wan</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Dae</forename><forename type="middle">Seog</forename><surname>Heo</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1349-7006.2011.02158.x</idno>
		<idno type="PMID">22107611</idno>
	</analytic>
	<monogr>
		<title level="j">Cancer Science</title>
		<idno type="ISSN">1347-9032</idno>
		<imprint>
			<biblScope unit="volume">103</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="155" to="160" />
			<date type="published" when="2011-12-23" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Influence of chemotherapy on nitric oxide synthase, indole-amine-2,3-dioxygenase and CD124 expression in granulocytes and monocytes of non-small cell lung cancer</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sung</forename><forename type="middle">Hoon</forename><surname>Sim</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yong-Oon</forename><surname>Ahn</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jieun</forename><surname>Yoon</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tae</forename><forename type="middle">Min</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Se-Hoon</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Dong-Wan</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Dae</forename><forename type="middle">Seog</forename><surname>Heo</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1349-7006.2011.02158.x</idno>
		<idno type="PMID">22107611</idno>
		<ptr target="http://dx.doi.org/10.1111/j.1349-7006.2011.02158.x" />
	</analytic>
	<monogr>
		<title level="j">Cancer Science</title>
		<idno type="ISSN">1347-9032</idno>
		<imprint>
			<biblScope unit="volume">103</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="155" to="160" />
			<date type="published" when="2011-12-23" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Intratumoral Immune Cell Infiltrates, FoxP3, and Indoleamine 2,3-Dioxygenase in Patients with Melanoma Undergoing CTLA4 Blockade</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Ribas</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><surname>Comin-Anduix</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">S</forename><surname>Economou</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><forename type="middle">R</forename><surname>Donahue</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>De La Rocha</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">F</forename><surname>Morris</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Jalil</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">V</forename><forename type="middle">B</forename><surname>Dissette</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">I</forename><forename type="middle">P</forename><surname>Shintaku</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">A</forename><surname>Glaspy</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Gomez-Navarro</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">J</forename><surname>Cochran</surname></persName>
		</author>
		<idno type="DOI">10.1158/1078-0432.ccr-08-0783</idno>
		<idno type="PMID">19118070</idno>
		<ptr type="open-access" target="https://clincancerres.aacrjournals.org/content/clincanres/15/1/390.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Clinical Cancer Research</title>
		<title level="j" type="abbrev">Clinical Cancer Research</title>
		<idno type="ISSN">1078-0432</idno>
		<idno type="ISSNe">1557-3265</idno>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="390" to="399" />
			<date type="published" when="2009-01-01" />
			<publisher>American Association for Cancer Research (AACR)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Plasma tryptophan, kynurenine and 3-hydroxykynurenine measurement using automated on-line solid-phase extraction HPLC–tandem mass spectrometry</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Wilhelmina</forename><forename type="middle">H A</forename><surname>De Jong</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Reinier</forename><surname>Smit</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Stephan</forename><forename type="middle">J L</forename><surname>Bakker</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Elisabeth</forename><forename type="middle">G E</forename><surname>De Vries</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ido</forename><forename type="middle">P</forename><surname>Kema</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jchromb.2009.01.015</idno>
		<idno type="PMID">19196554</idno>
		<ptr target="http://dx.doi.org/10.1016/j.jchromb.2009.01.015" />
	</analytic>
	<monogr>
		<title level="j">Journal of Chromatography B</title>
		<title level="j" type="abbrev">Journal of Chromatography B</title>
		<idno type="ISSN">1570-0232</idno>
		<imprint>
			<biblScope unit="volume">877</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="603" to="609" />
			<date type="published" when="2009-03" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Plasma tryptophan, kynurenine and 3-hydroxykynurenine measurement using automated on-line solid-phase extraction HPLC–tandem mass spectrometry</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Wilhelmina</forename><forename type="middle">H A</forename><surname>De Jong</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Reinier</forename><surname>Smit</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Stephan</forename><forename type="middle">J L</forename><surname>Bakker</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Elisabeth</forename><forename type="middle">G E</forename><surname>De Vries</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ido</forename><forename type="middle">P</forename><surname>Kema</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jchromb.2009.01.015</idno>
		<idno type="PMID">19196554</idno>
		<ptr target="http://dx.doi.org/10.1016/j.jchromb.2009.01.015" />
	</analytic>
	<monogr>
		<title level="j">Journal of Chromatography B</title>
		<title level="j" type="abbrev">Journal of Chromatography B</title>
		<idno type="ISSN">1570-0232</idno>
		<imprint>
			<biblScope unit="volume">877</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="603" to="609" />
			<date type="published" when="2009-03" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">5-Fluorouracil Selectively Kills Tumor-Associated Myeloid-Derived Suppressor Cells Resulting in Enhanced T Cell-Dependent Antitumor Immunity</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Vincent</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Mignot</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><surname>Chalmin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Ladoire</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Bruchard</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Chevriaux</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><surname>Martin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Apetoh</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Rebe</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><surname>Ghiringhelli</surname></persName>
		</author>
		<idno type="DOI">10.1158/0008-5472.can-09-3690</idno>
		<idno type="PMID">20388795</idno>
		<ptr type="open-access" target="http://cancerres.aacrjournals.org/content/70/8/3052.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Cancer Research</title>
		<title level="j" type="abbrev">Cancer Research</title>
		<idno type="ISSN">0008-5472</idno>
		<idno type="ISSNe">1538-7445</idno>
		<imprint>
			<biblScope unit="volume">70</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="3052" to="3061" />
			<date type="published" when="2010-04-13" />
			<publisher>American Association for Cancer Research (AACR)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">5-Fluorouracil Selectively Kills Tumor-Associated Myeloid-Derived Suppressor Cells Resulting in Enhanced T Cell-Dependent Antitumor Immunity</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Vincent</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Mignot</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><surname>Chalmin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Ladoire</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Bruchard</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Chevriaux</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><surname>Martin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Apetoh</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Rebe</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><surname>Ghiringhelli</surname></persName>
		</author>
		<idno type="DOI">10.1158/0008-5472.can-09-3690</idno>
		<idno type="PMID">20388795</idno>
		<ptr type="open-access" target="http://cancerres.aacrjournals.org/content/70/8/3052.full.pdf" />
		<ptr target="http://dx.doi.org/10.1158/0008-5472.CAN-09-3690" />
	</analytic>
	<monogr>
		<title level="j">Cancer Research</title>
		<title level="j" type="abbrev">Cancer Research</title>
		<idno type="ISSN">0008-5472</idno>
		<idno type="ISSNe">1538-7445</idno>
		<imprint>
			<biblScope unit="volume">70</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="3052" to="3061" />
			<date type="published" when="2010-04-13" />
			<publisher>American Association for Cancer Research (AACR)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Effect of Chemotherapy on the Tumor Microenvironment and Anti-tumor Immunity</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tarek</forename><forename type="middle">M</forename><surname>Meniawy</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Anna</forename><forename type="middle">K</forename><surname>Nowak</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Richard</forename><forename type="middle">A</forename><surname>Lake</surname></persName>
		</author>
		<idno type="DOI">10.1007/978-94-007-4694-7_1</idno>
	</analytic>
	<monogr>
		<title level="m">Tumor Ablation</title>
		<imprint>
			<publisher>Springer Netherlands</publisher>
			<date type="published" when="2012-08-15" />
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page" from="1" to="28" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Effect of Chemotherapy on the Tumor Microenvironment and Anti-tumor Immunity</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tarek</forename><forename type="middle">M</forename><surname>Meniawy</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Anna</forename><forename type="middle">K</forename><surname>Nowak</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Richard</forename><forename type="middle">A</forename><surname>Lake</surname></persName>
		</author>
		<idno type="DOI">10.1007/978-94-007-4694-7_1</idno>
		<ptr target="http://dx.doi.org/10.1007/978-94-007-4694-7_1" />
	</analytic>
	<monogr>
		<title level="m">Tumor Ablation</title>
		<imprint>
			<publisher>Springer Netherlands</publisher>
			<date type="published" when="2012-08-15" />
			<biblScope unit="page" from="1" to="28" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<monogr>
		<title level="m" type="main">Multiple comparisons: theory and methods</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Hsu</surname></persName>
		</author>
		<imprint>
			<date type="published" when="1996" />
			<publisher>Chapman &amp; Hall/CRC</publisher>
			<pubPlace>London</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">A phase I study of indoximod in patients with advanced malignancies</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hatem</forename><forename type="middle">H</forename><surname>Soliman</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Susan</forename><forename type="middle">E</forename><surname>Minton</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hyo</forename><forename type="middle">Sook</forename><surname>Han</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Roohi</forename><surname>Ismail-Khan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Anthony</forename><surname>Neuger</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Fatema</forename><surname>Khambati</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">David</forename><surname>Noyes</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Richard</forename><surname>Lush</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Alberto</forename><forename type="middle">A</forename><surname>Chiappori</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">John</forename><forename type="middle">D</forename><surname>Roberts</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Charles</forename><surname>Link</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Nicholas</forename><forename type="middle">N</forename><surname>Vahanian</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mario</forename><surname>Mautino</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Howard</forename><surname>Streicher</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Daniel</forename><forename type="middle">M</forename><surname>Sullivan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Scott</forename><forename type="middle">J</forename><surname>Antonia</surname></persName>
		</author>
		<idno type="DOI">10.18632/oncotarget.8216</idno>
		<idno type="PMID">27008709</idno>
		<idno type="PMCID">PMC5008412</idno>
		<ptr type="open-access" target="http://www.oncotarget.com/index.php?journal=oncotarget&amp;page=article&amp;op=download&amp;path%5B%5D=8216&amp;path%5B%5D=24291" />
	</analytic>
	<monogr>
		<title level="j">Oncotarget</title>
		<title level="j" type="abbrev">Oncotarget</title>
		<idno type="ISSNe">1949-2553</idno>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="issue">16</biblScope>
			<date type="published" when="2016-03-20" />
			<publisher>Impact Journals, LLC</publisher>
		</imprint>
	</monogr>
	<note>supplement</note>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">J Clin Oncol</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="page">2501</biblScope>
			<date type="published" when="2012" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Phase II Trial of Induction Gemcitabine and Carboplatin Followed by Conformal Thoracic Radiation to 74 Gy with Weekly Paclitaxel and Carboplatin in Unresectable Stage III Non-small Cell Lung Cancer</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Gerold</forename><surname>Bepler</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Thomas</forename><forename type="middle">J</forename><surname>Dilling</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Henry</forename><surname>Wagner</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Todd</forename><surname>Hazelton</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Charles</forename><surname>Williams</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Dung-Tsa</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Harvey</forename><surname>Greenberg</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Frank</forename><surname>Walsh</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">George</forename><surname>Simon</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tawee</forename><surname>Tanvetyanon</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Alberto</forename><surname>Chiappori</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Eric</forename><surname>Haura</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Craig</forename><surname>Stevens</surname></persName>
		</author>
		<idno type="DOI">10.1097/jto.0b013e31820b8d88</idno>
		<idno type="PMID">21289520</idno>
		<idno type="PMCID">PMC3839293</idno>
		<ptr type="open-access" target="http://europepmc.org/articles/pmc3839293?pdf=render" />
	</analytic>
	<monogr>
		<title level="j">Journal of Thoracic Oncology</title>
		<title level="j" type="abbrev">Journal of Thoracic Oncology</title>
		<idno type="ISSN">1556-0864</idno>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="553" to="558" />
			<date type="published" when="2011-03" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Phase II Trial of Induction Gemcitabine and Carboplatin Followed by Conformal Thoracic Radiation to 74 Gy with Weekly Paclitaxel and Carboplatin in Unresectable Stage III Non-small Cell Lung Cancer</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Gerold</forename><surname>Bepler</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Thomas</forename><forename type="middle">J</forename><surname>Dilling</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Henry</forename><surname>Wagner</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Todd</forename><surname>Hazelton</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Charles</forename><surname>Williams</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Dung-Tsa</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Harvey</forename><surname>Greenberg</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Frank</forename><surname>Walsh</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">George</forename><surname>Simon</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tawee</forename><surname>Tanvetyanon</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Alberto</forename><surname>Chiappori</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Eric</forename><surname>Haura</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Craig</forename><surname>Stevens</surname></persName>
		</author>
		<idno type="DOI">10.1097/jto.0b013e31820b8d88</idno>
		<idno type="PMID">21289520</idno>
		<idno type="PMCID">PMC3839293</idno>
		<ptr type="open-access" target="http://europepmc.org/articles/pmc3839293?pdf=render" />
		<ptr target="http://dx.doi.org/10.1097/JTO.0b013e31820b8d88" />
	</analytic>
	<monogr>
		<title level="j">Journal of Thoracic Oncology</title>
		<title level="j" type="abbrev">Journal of Thoracic Oncology</title>
		<idno type="ISSN">1556-0864</idno>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="553" to="558" />
			<date type="published" when="2011-03" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Immune biomarker panel monitoring utilizing IDO enzyme activity and CD4 ATP levels: Prediction of acute rejection vs. viral replication events</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Vikas</forename><forename type="middle">R</forename><surname>Dharnidharka</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sushil</forename><surname>Gupta</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Eihab</forename><surname>Al Khasawneh</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Allah</forename><surname>Haafiz</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jonathan</forename><forename type="middle">J</forename><surname>Shuster</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Douglas</forename><forename type="middle">W</forename><surname>Theriaque</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Amir</forename><forename type="middle">H</forename><surname>Shahlaee</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Timothy</forename><forename type="middle">J</forename><surname>Garrett</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1399-3046.2011.01485.x</idno>
		<idno type="PMID">21492353</idno>
		<idno type="PMCID">PMC3078420</idno>
		<idno type="ark">ark:/67375/WNG-9JQ8BFNH-7</idno>
		<idno type="istexId">6F344A04034D30CD82422A0B7779066D4A28F223</idno>
		<ptr type="open-access" target="http://europepmc.org/articles/pmc3078420?pdf=render" />
	</analytic>
	<monogr>
		<title level="j">Pediatric Transplantation</title>
		<idno type="ISSN">1397-3142</idno>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="321" to="328" />
			<date type="published" when="2011-02-24" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Immune biomarker panel monitoring utilizing IDO enzyme activity and CD4 ATP levels: Prediction of acute rejection vs. viral replication events</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Vikas</forename><forename type="middle">R</forename><surname>Dharnidharka</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sushil</forename><surname>Gupta</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Eihab</forename><surname>Al Khasawneh</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Allah</forename><surname>Haafiz</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jonathan</forename><forename type="middle">J</forename><surname>Shuster</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Douglas</forename><forename type="middle">W</forename><surname>Theriaque</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Amir</forename><forename type="middle">H</forename><surname>Shahlaee</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Timothy</forename><forename type="middle">J</forename><surname>Garrett</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1399-3046.2011.01485.x</idno>
		<idno type="PMID">21492353</idno>
		<idno type="PMCID">PMC3078420</idno>
		<idno type="ark">ark:/67375/WNG-9JQ8BFNH-7</idno>
		<idno type="istexId">6F344A04034D30CD82422A0B7779066D4A28F223</idno>
		<ptr type="open-access" target="http://europepmc.org/articles/pmc3078420?pdf=render" />
		<ptr target="http://dx.doi.org/10.1111/j.1399-3046.2011.01485.x" />
	</analytic>
	<monogr>
		<title level="j">Pediatric Transplantation</title>
		<idno type="ISSN">1397-3142</idno>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="321" to="328" />
			<date type="published" when="2011-02-24" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Role of the immunosuppressive enzyme indoleamine 2,3-dioxygenase in the progression of ovarian carcinoma</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tomoko</forename><surname>Inaba</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kazuhiko</forename><surname>Ino</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hiroaki</forename><surname>Kajiyama</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Eiko</forename><surname>Yamamoto</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kiyosumi</forename><surname>Shibata</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Akihiro</forename><surname>Nawa</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tetsuro</forename><surname>Nagasaka</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hidetoshi</forename><surname>Akimoto</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Osamu</forename><surname>Takikawa</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Fumitaka</forename><surname>Kikkawa</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.ygyno.2009.07.015</idno>
		<idno type="PMID">19665763</idno>
		<ptr target="http://dx.doi.org/10.1016/j.ygyno.2009.07.015" />
	</analytic>
	<monogr>
		<title level="j">Gynecologic Oncology</title>
		<title level="j" type="abbrev">Gynecologic Oncology</title>
		<idno type="ISSN">0090-8258</idno>
		<imprint>
			<biblScope unit="volume">115</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="185" to="192" />
			<date type="published" when="2009-11" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Expression of Indoleamine 2,3-Dioxygenase in Tumor Endothelial Cells Correlates with Long-term Survival of Patients with Renal Cell Carcinoma</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Riesenberg</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Weiler</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">O</forename><surname>Spring</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Eder</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Buchner</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Popp</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Castro</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Kammerer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">O</forename><surname>Takikawa</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">A</forename><surname>Hatz</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">G</forename><surname>Stief</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Hofstetter</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><surname>Zimmermann</surname></persName>
		</author>
		<idno type="DOI">10.1158/1078-0432.ccr-07-0942</idno>
		<idno type="PMID">18056175</idno>
		<ptr type="open-access" target="http://clincancerres.aacrjournals.org/content/13/23/6993.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Clinical Cancer Research</title>
		<title level="j" type="abbrev">Clinical Cancer Research</title>
		<idno type="ISSN">1078-0432</idno>
		<idno type="ISSNe">1557-3265</idno>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="issue">23</biblScope>
			<biblScope unit="page" from="6993" to="7002" />
			<date type="published" when="2007-12-01" />
			<publisher>American Association for Cancer Research (AACR)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Expression of Indoleamine 2,3-Dioxygenase in Tumor Endothelial Cells Correlates with Long-term Survival of Patients with Renal Cell Carcinoma</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Riesenberg</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Weiler</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">O</forename><surname>Spring</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Eder</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Buchner</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Popp</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Castro</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Kammerer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">O</forename><surname>Takikawa</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">A</forename><surname>Hatz</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">G</forename><surname>Stief</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Hofstetter</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><surname>Zimmermann</surname></persName>
		</author>
		<idno type="DOI">10.1158/1078-0432.ccr-07-0942</idno>
		<idno type="PMID">18056175</idno>
		<ptr type="open-access" target="http://clincancerres.aacrjournals.org/content/13/23/6993.full.pdf" />
		<ptr target="http://dx.doi.org/10.1158/1078-0432.CCR-07-0942" />
	</analytic>
	<monogr>
		<title level="j">Clinical Cancer Research</title>
		<title level="j" type="abbrev">Clinical Cancer Research</title>
		<idno type="ISSN">1078-0432</idno>
		<idno type="ISSNe">1557-3265</idno>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="issue">23</biblScope>
			<biblScope unit="page" from="6993" to="7002" />
			<date type="published" when="2007-12-01" />
			<publisher>American Association for Cancer Research (AACR)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Expression and prognosis role of indoleamine 2,3-dioxygenase in hepatocellular carcinoma</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ke</forename><surname>Pan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hui</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Min-Shan</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hua-Kun</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">De-Sheng</forename><surname>Weng</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jun</forename><surname>Zhou</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Wei</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jian-Jun</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hai-Feng</forename><surname>Song</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jian-Chuan</forename><surname>Xia</surname></persName>
		</author>
		<idno type="DOI">10.1007/s00432-008-0395-1</idno>
		<idno type="PMID">18438685</idno>
		<idno type="ark">ark:/67375/VQC-37DGS55W-V</idno>
		<idno type="istexId">2C7B41BEE9A91DC9B567DDB15232F58A6AA12739</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of Cancer Research and Clinical Oncology</title>
		<title level="j" type="abbrev">J Cancer Res Clin Oncol</title>
		<idno type="ISSN">0171-5216</idno>
		<idno type="ISSNe">1432-1335</idno>
		<imprint>
			<biblScope unit="volume">134</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="1247" to="1253" />
			<date type="published" when="2008-04-26" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Expression and prognosis role of indoleamine 2,3-dioxygenase in hepatocellular carcinoma</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ke</forename><surname>Pan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hui</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Min-Shan</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hua-Kun</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">De-Sheng</forename><surname>Weng</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jun</forename><surname>Zhou</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Wei</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jian-Jun</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hai-Feng</forename><surname>Song</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jian-Chuan</forename><surname>Xia</surname></persName>
		</author>
		<idno type="DOI">10.1007/s00432-008-0395-1</idno>
		<idno type="PMID">18438685</idno>
		<idno type="ark">ark:/67375/VQC-37DGS55W-V</idno>
		<idno type="istexId">2C7B41BEE9A91DC9B567DDB15232F58A6AA12739</idno>
		<ptr target="http://dx.doi.org/10.1007/s00432-008-0395-1" />
	</analytic>
	<monogr>
		<title level="j">Journal of Cancer Research and Clinical Oncology</title>
		<title level="j" type="abbrev">J Cancer Res Clin Oncol</title>
		<idno type="ISSN">0171-5216</idno>
		<idno type="ISSNe">1432-1335</idno>
		<imprint>
			<biblScope unit="volume">134</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="1247" to="1253" />
			<date type="published" when="2008-04-26" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">A randomized trial of adoptive immunotherapy with tumor-infiltrating lymphocytes and interleukin-2 versus standard therapy in the postoperative treatment of resected nonsmall cell lung cancer</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Giovanni</forename><forename type="middle">B</forename><surname>Ratto</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Paolo</forename><surname>Zino</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sandro</forename><surname>Mirabelli</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Paolo</forename><surname>Minuti</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Riccardo</forename><surname>Aquilina</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Giovanni</forename><surname>Fantino</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Elisabetta</forename><surname>Spessa</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Marco</forename><surname>Ponte</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Paolo</forename><surname>Bruzzi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Giovanni</forename><surname>Melioli</surname></persName>
		</author>
		<idno type="DOI">10.1002/(sici)1097-0142(19960715)78:2&lt;244::aid-cncr9&gt;3.0.co;2-l</idno>
		<idno type="PMID">8673999</idno>
		<ptr target="http://dx.doi.org/10.1002/(SICI" />
	</analytic>
	<monogr>
		<title level="j">Cancer</title>
		<title level="j" type="abbrev">Cancer</title>
		<idno type="ISSN">0008-543X</idno>
		<idno type="ISSNe">1097-0142</idno>
		<imprint>
			<biblScope unit="volume">78</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="244" to="251" />
			<date type="published" when="1996-07-15" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
	<note>2&lt;244::AID-CNCR9&gt;3.0.CO;2-L</note>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Eosinophil Granulocytes Account for Indoleamine 2,3-Dioxygenase-Mediated Immune Escape in Human Non Small Cell Lung Cancer</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Simonetta</forename><surname>Astigiano</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Barbara</forename><surname>Morandi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Roberta</forename><surname>Costa</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Luca</forename><surname>Mastracci</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Antonella</forename><surname>D'agostino</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Giovanni</forename><forename type="middle">Battista</forename><surname>Ratto</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Giovanni</forename><surname>Melioli</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Guido</forename><surname>Frumento</surname></persName>
		</author>
		<idno type="DOI">10.1593/neo.04658</idno>
		<idno type="PMID">15967116</idno>
		<idno type="PMCID">PMC1501151</idno>
		<ptr target="http://dx.doi.org/10.1593/neo.04658" />
	</analytic>
	<monogr>
		<title level="j">Neoplasia</title>
		<title level="j" type="abbrev">Neoplasia</title>
		<idno type="ISSN">1476-5586</idno>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="390" to="396" />
			<date type="published" when="2005-04" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Serum Tryptophan and Kynurenine Concentrations as Parameters for Indoleamine 2,3-Dioxygenase Activity in Patients With Endometrial, Ovarian, and Vulvar Cancer</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Renske</forename><forename type="middle">A</forename><surname>De Jong</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hans</forename><forename type="middle">W</forename><surname>Nijman</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><forename type="middle">Marike</forename><surname>Boezen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Marcel</forename><surname>Volmer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Klaske</forename><forename type="middle">A</forename><surname>Ten Hoor</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jasper</forename><surname>Krijnen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ate</forename><forename type="middle">G J</forename><surname>Van Der Zee</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Harry</forename><surname>Hollema</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ido</forename><forename type="middle">P</forename><surname>Kema</surname></persName>
		</author>
		<idno type="DOI">10.1097/igc.0b013e31822017fb</idno>
		<idno type="PMID">21720257</idno>
	</analytic>
	<monogr>
		<title level="j">International Journal of Gynecological Cancer</title>
		<title level="j" type="abbrev">International Journal of Gynecological Cancer</title>
		<idno type="ISSN">1048-891X</idno>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page">1</biblScope>
			<date type="published" when="2011-06" />
			<publisher>Ovid Technologies (Wolters Kluwer Health)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">High expression of indoleamine 2,3-dioxygenase gene in prostate cancer</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Chantal</forename><surname>Feder-Mengus</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Stephen</forename><surname>Wyler</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tvrtko</forename><surname>Hudolin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Robin</forename><surname>Ruszat</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Lukas</forename><surname>Bubendorf</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Alberto</forename><surname>Chiarugi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Maria</forename><surname>Pittelli</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Walter</forename><forename type="middle">P</forename><surname>Weber</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Alexander</forename><surname>Bachmann</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Thomas</forename><forename type="middle">C</forename><surname>Gasser</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tullio</forename><surname>Sulser</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Michael</forename><surname>Heberer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Giulio</forename><forename type="middle">C</forename><surname>Spagnoli</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Maurizio</forename><surname>Provenzano</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.ejca.2008.05.023</idno>
		<idno type="PMID">18619832</idno>
		<ptr type="open-access" target="https://www.zora.uzh.ch/id/eprint/3114/4/Binder1Federer.pdf" />
	</analytic>
	<monogr>
		<title level="j">European Journal of Cancer</title>
		<title level="j" type="abbrev">European Journal of Cancer</title>
		<idno type="ISSN">0959-8049</idno>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="issue">15</biblScope>
			<biblScope unit="page" from="2266" to="2275" />
			<date type="published" when="2008-10" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">High expression of indoleamine 2,3-dioxygenase gene in prostate cancer</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Chantal</forename><surname>Feder-Mengus</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Stephen</forename><surname>Wyler</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tvrtko</forename><surname>Hudolin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Robin</forename><surname>Ruszat</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Lukas</forename><surname>Bubendorf</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Alberto</forename><surname>Chiarugi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Maria</forename><surname>Pittelli</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Walter</forename><forename type="middle">P</forename><surname>Weber</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Alexander</forename><surname>Bachmann</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Thomas</forename><forename type="middle">C</forename><surname>Gasser</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tullio</forename><surname>Sulser</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Michael</forename><surname>Heberer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Giulio</forename><forename type="middle">C</forename><surname>Spagnoli</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Maurizio</forename><surname>Provenzano</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.ejca.2008.05.023</idno>
		<idno type="PMID">18619832</idno>
		<ptr type="open-access" target="https://www.zora.uzh.ch/id/eprint/3114/4/Binder1Federer.pdf" />
		<ptr target="http://dx.doi.org/10.1016/j.ejca.2008.05.023" />
	</analytic>
	<monogr>
		<title level="j">European Journal of Cancer</title>
		<title level="j" type="abbrev">European Journal of Cancer</title>
		<idno type="ISSN">0959-8049</idno>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="issue">15</biblScope>
			<biblScope unit="page" from="2266" to="2275" />
			<date type="published" when="2008-10" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">The expression and significance of indoleamine -2,3 -dioxygenase in non-small cell lung cancer cell</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Q</forename><surname>Xie</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><surname>Zhu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Gu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Z</forename><surname>Chen</surname></persName>
		</author>
		<idno type="PMID">20727279</idno>
	</analytic>
	<monogr>
		<title level="j">Zhongguo Fei Ai Za Zhi</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="115" to="124" />
			<date type="published" when="2008" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">Decreased Serum Tryptophan Concentration Predicts Poor Prognosis in Malignant Melanoma Patients</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Georg</forename><surname>Weinlich</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Christian</forename><surname>Murr</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Laura</forename><surname>Richardsen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Christiana</forename><surname>Winkler</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Dietmar</forename><surname>Fuchs</surname></persName>
		</author>
		<idno type="DOI">10.1159/000096906</idno>
		<idno type="PMID">17191041</idno>
	</analytic>
	<monogr>
		<title level="j">Dermatology</title>
		<title level="j" type="abbrev">Dermatology</title>
		<idno type="ISSN">1018-8665</idno>
		<idno type="ISSNe">1421-9832</idno>
		<imprint>
			<biblScope unit="volume">214</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="8" to="14" />
			<date type="published" when="2006-12-22" />
			<publisher>S. Karger AG</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">Decreased Serum Tryptophan Concentration Predicts Poor Prognosis in Malignant Melanoma Patients</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Georg</forename><surname>Weinlich</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Christian</forename><surname>Murr</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Laura</forename><surname>Richardsen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Christiana</forename><surname>Winkler</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Dietmar</forename><surname>Fuchs</surname></persName>
		</author>
		<idno type="DOI">10.1159/000096906</idno>
		<idno type="PMID">17191041</idno>
		<ptr target="http://dx.doi.org/10.1159/000096906" />
	</analytic>
	<monogr>
		<title level="j">Dermatology</title>
		<title level="j" type="abbrev">Dermatology</title>
		<idno type="ISSN">1018-8665</idno>
		<idno type="ISSNe">1421-9832</idno>
		<imprint>
			<biblScope unit="volume">214</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="8" to="14" />
			<date type="published" when="2006-12-22" />
			<publisher>S. Karger AG</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">Changes in the levels of thioredoxin and indoleamine-2,3-dioxygenase activity in plasma of patients with colorectal cancer treated with chemotherapy</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Monica</forename><surname>Cavia-Saiz</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Pilar</forename><surname>Muñiz</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Reyes</forename><surname>De Santiago</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Marta</forename><surname>Herreros-Villanueva</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Carlos</forename><surname>Garcia-Giron</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ana</forename><forename type="middle">Sofia</forename><surname>Lopez</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Maria</forename><forename type="middle">Jesus</forename><surname>Coma-Del Corral</surname></persName>
		</author>
		<idno type="DOI">10.1139/o11-077</idno>
		<idno type="PMID">22257103</idno>
		<ptr target="http://dx.doi.org/10.1139/o11-077" />
	</analytic>
	<monogr>
		<title level="j">Biochemistry and Cell Biology</title>
		<title level="j" type="abbrev">Biochem. Cell Biol.</title>
		<idno type="ISSN">0829-8211</idno>
		<idno type="ISSNe">1208-6002</idno>
		<imprint>
			<biblScope unit="volume">90</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="173" to="178" />
			<date type="published" when="2012-04" />
			<publisher>Canadian Science Publishing</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">Localization of indoleamine 2,3-dioxygenase in human esophageal squamous cell carcinomas</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jinzhong</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Gaofeng</forename><surname>Lu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Fuai</forename><surname>Tang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yiqing</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Guanglin</forename><surname>Cui</surname></persName>
		</author>
		<idno type="DOI">10.1007/s00428-009-0846-3</idno>
		<idno type="PMID">19844741</idno>
		<idno type="ark">ark:/67375/VQC-VL1N365J-9</idno>
		<idno type="istexId">A048392D6147FF758FDB03A082C67F0A29350F3A</idno>
		<ptr target="http://dx.doi.org/10.1007/s00428-009-0846-3" />
	</analytic>
	<monogr>
		<title level="j">Virchows Archiv</title>
		<title level="j" type="abbrev">Virchows Arch</title>
		<idno type="ISSN">0945-6317</idno>
		<idno type="ISSNe">1432-2307</idno>
		<imprint>
			<biblScope unit="volume">455</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="441" to="448" />
			<date type="published" when="2009-10-21" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">Study of indoleamine 2,3-dioxygenase expression in patients of esophageal squamous cell carcinoma</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Sakurai</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Enomoto</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Amano</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Kimura</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Sugito</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Kimizuka</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gan To Kagaku Ryoho</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="page" from="1780" to="1782" />
			<date type="published" when="2004" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">Study of indoleamine 2,3-dioxygenase expression in patients of thyroid cancer</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Sakurai</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Fujisaki</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Nagashima</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Shibata</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Maeda</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Ueda</surname></persName>
		</author>
		<idno type="PMID">22202241</idno>
	</analytic>
	<monogr>
		<title level="j">Gan To Kagaku Ryoho</title>
		<imprint>
			<biblScope unit="volume">38</biblScope>
			<biblScope unit="page" from="1927" to="1936" />
			<date type="published" when="2011" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main">High INDO (indoleamine 2,3-dioxygenase) mRNA level in blasts of acute myeloid leukemic patients predicts poor clinical outcome</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Med</forename><forename type="middle">E D</forename><surname>Chamuleau</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">A</forename><surname>Van De Loosdrecht</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">J</forename><surname>Hess</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jjwm</forename><forename type="middle">J W M</forename><surname>Janssen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Zevenbergen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Delwel</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">J M</forename><surname>Valk</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><surname>Lowenberg</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><forename type="middle">J</forename><surname>Ossenkoppele</surname></persName>
		</author>
		<idno type="DOI">10.3324/haematol.13112</idno>
		<idno type="PMID">19050070</idno>
		<ptr type="open-access" target="http://www.haematologica.org/content/93/12/1894.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Haematologica</title>
		<title level="j" type="abbrev">Haematologica</title>
		<idno type="ISSN">0390-6078</idno>
		<idno type="ISSNe">1592-8721</idno>
		<imprint>
			<biblScope unit="volume">93</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="1894" to="1898" />
			<date type="published" when="2008-09-02" />
			<publisher>Ferrata Storti Foundation (Haematologica)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b49">
	<monogr>
		<title/>
		<idno type="DOI">10.3324/haema-tol.13112</idno>
		<idno type="PMID">19050070</idno>
		<ptr target="http://dx.doi.org/10.3324/haema-tol.13112" />
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main">Tryptophan degradation in women with breast cancer: a pilot study</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Debra</forename><forename type="middle">E</forename><surname>Lyon</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jeanne</forename><forename type="middle">M</forename><surname>Walter</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Angela</forename><forename type="middle">R</forename><surname>Starkweather</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Christine</forename><forename type="middle">M</forename><surname>Schubert</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Nancy</forename><forename type="middle">L</forename><surname>Mccain</surname></persName>
		</author>
		<idno type="DOI">10.1186/1756-0500-4-156</idno>
		<idno type="PMID">21615916</idno>
		<idno type="PMCID">PMC3117722</idno>
		<ptr type="open-access" target="https://bmcresnotes.biomedcentral.com/track/pdf/10.1186/1756-0500-4-156" />
		<ptr target="http://dx.doi.org/10.1186/1756-0500-4-156" />
	</analytic>
	<monogr>
		<title level="j">BMC Research Notes</title>
		<title level="j" type="abbrev">BMC Research Notes</title>
		<idno type="ISSN">1756-0500</idno>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">156</biblScope>
			<date type="published" when="2011" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main">Quantification of Tryptophan Transport and Metabolism in Lung Tumors Using PET</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Juhasz</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">O</forename><surname>Muzik</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">X</forename><surname>Lu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">S</forename><surname>Jahania</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">O</forename><surname>Soubani</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Khalaf</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><surname>Peng</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><forename type="middle">J</forename><surname>Mangner</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">K</forename><surname>Chakraborty</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">C</forename><surname>Chugani</surname></persName>
		</author>
		<idno type="DOI">10.2967/jnumed.108.058776</idno>
		<idno type="PMID">19223408</idno>
		<idno type="PMCID">PMC2784997</idno>
		<ptr type="open-access" target="http://jnm.snmjournals.org/content/50/3/356.full.pdf" />
		<ptr target="http://dx.doi.org/10.2967/jnumed.108.058776" />
	</analytic>
	<monogr>
		<title level="j">Journal of Nuclear Medicine</title>
		<title level="j" type="abbrev">Journal of Nuclear Medicine</title>
		<idno type="ISSN">0161-5505</idno>
		<imprint>
			<biblScope unit="volume">50</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="356" to="363" />
			<date type="published" when="2009-02-17" />
			<publisher>Society of Nuclear Medicine</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main">Indoleamine 2,3-Dioxygenase Serves as a Marker of Poor Prognosis in Gene Expression Profiles of Serous Ovarian Cancer Cells</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Okamoto</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Nikaido</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Ochiai</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Takakura</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Saito</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Aoki</surname></persName>
		</author>
		<idno type="DOI">10.1158/1078-0432.ccr-04-2671</idno>
		<idno type="PMID">16115948</idno>
		<ptr type="open-access" target="http://clincancerres.aacrjournals.org/content/11/16/6030.full.pdf" />
		<ptr target="http://dx.doi.org/10.1158/1078-0432.CCR-04-2671" />
	</analytic>
	<monogr>
		<title level="j">Clinical Cancer Research</title>
		<title level="j" type="abbrev">Clinical Cancer Research</title>
		<idno type="ISSN">1078-0432</idno>
		<idno type="ISSNe">1557-3265</idno>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="issue">16</biblScope>
			<biblScope unit="page" from="6030" to="6039" />
			<date type="published" when="2005-08-15" />
			<publisher>American Association for Cancer Research (AACR)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main">Dendritic cell based antitumor vaccination: impact of functional indoleamine 2,3-dioxygenase expression</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Marion</forename><surname>Wobser</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Heike</forename><surname>Voigt</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Roland</forename><surname>Houben</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Andreas</forename><forename type="middle">O</forename><surname>Eggert</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Matthias</forename><surname>Freiwald</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ulrike</forename><surname>Kaemmerer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Eckhart</forename><surname>Kaempgen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">David</forename><surname>Schrama</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Juergen</forename><forename type="middle">C</forename><surname>Becker</surname></persName>
		</author>
		<idno type="DOI">10.1007/s00262-006-0256-1</idno>
		<idno type="PMID">17195079</idno>
		<idno type="ark">ark:/67375/VQC-65XTQZTQ-1</idno>
		<idno type="istexId">B2A563E5FE5E8DFCC9BC36AE9B01019458A21D85</idno>
	</analytic>
	<monogr>
		<title level="j">Cancer Immunology, Immunotherapy</title>
		<title level="j" type="abbrev">Cancer Immunol Immunother</title>
		<idno type="ISSN">0340-7004</idno>
		<idno type="ISSNe">1432-0851</idno>
		<imprint>
			<biblScope unit="volume">56</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="1017" to="1024" />
			<date type="published" when="2006-12-29" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b54">
	<analytic>
		<title level="a" type="main">Dendritic cell based antitumor vaccination: impact of functional indoleamine 2,3-dioxygenase expression</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Marion</forename><surname>Wobser</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Heike</forename><surname>Voigt</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Roland</forename><surname>Houben</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Andreas</forename><forename type="middle">O</forename><surname>Eggert</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Matthias</forename><surname>Freiwald</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ulrike</forename><surname>Kaemmerer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Eckhart</forename><surname>Kaempgen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">David</forename><surname>Schrama</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Juergen</forename><forename type="middle">C</forename><surname>Becker</surname></persName>
		</author>
		<idno type="DOI">10.1007/s00262-006-0256-1</idno>
		<idno type="PMID">17195079</idno>
		<idno type="ark">ark:/67375/VQC-65XTQZTQ-1</idno>
		<idno type="istexId">B2A563E5FE5E8DFCC9BC36AE9B01019458A21D85</idno>
		<ptr target="http://dx.doi.org/10.1007/s00262-006-0256-1" />
	</analytic>
	<monogr>
		<title level="j">Cancer Immunology, Immunotherapy</title>
		<title level="j" type="abbrev">Cancer Immunol Immunother</title>
		<idno type="ISSN">0340-7004</idno>
		<idno type="ISSNe">1432-0851</idno>
		<imprint>
			<biblScope unit="volume">56</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="1017" to="1024" />
			<date type="published" when="2006-12-29" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b55">
	<analytic>
		<title level="a" type="main">Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Alexander</forename><forename type="middle">J</forename><surname>Muller</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">James</forename><forename type="middle">B</forename><surname>Duhadaway</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">Scott</forename><surname>Donover</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Erika</forename><surname>Sutanto-Ward</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">George</forename><forename type="middle">C</forename><surname>Prendergast</surname></persName>
		</author>
		<idno type="DOI">10.1038/nm1196</idno>
		<idno type="PMID">15711557</idno>
		<ptr target="http://dx.doi.org/10.1038/nm1196" />
	</analytic>
	<monogr>
		<title level="j">Nature Medicine</title>
		<title level="j" type="abbrev">Nat Med</title>
		<idno type="ISSN">1078-8956</idno>
		<idno type="ISSNe">1546-170X</idno>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="312" to="319" />
			<date type="published" when="2005-02-13" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b56">
	<analytic>
		<title level="a" type="main">Indoleamine 2,3-dioxygenase (IDO) expression in lung cancer</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Vaios</forename><surname>Karanikas</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Maria</forename><surname>Zamanakou</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Theodora</forename><surname>Kerenidi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jubrail</forename><surname>Dahabreh</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Athanasios</forename><surname>Hevas</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Marianna</forename><surname>Nakou</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Konstantinos</forename><forename type="middle">I</forename><surname>Gourgoulianis</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Anastasios</forename><forename type="middle">E</forename><surname>Germenis</surname></persName>
		</author>
		<idno type="DOI">10.4161/cbt.6.8.4446</idno>
		<idno type="PMID">17700060</idno>
		<ptr type="open-access" target="https://www.tandfonline.com/doi/pdf/10.4161/cbt.6.8.4446?needAccess=true" />
	</analytic>
	<monogr>
		<title level="j">Cancer Biology &amp; Therapy</title>
		<title level="j" type="abbrev">Cancer Biology &amp; Therapy</title>
		<idno type="ISSN">1538-4047</idno>
		<idno type="ISSNe">1555-8576</idno>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="1269" to="1268" />
			<date type="published" when="2007-08" />
			<publisher>Informa UK Limited</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b57">
	<analytic>
		<title level="a" type="main">Cancer Statistics, 2007</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Jemal</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Siegel</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><surname>Ward</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Murray</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">J</forename><surname>Thun</surname></persName>
		</author>
		<idno type="DOI">10.3322/canjclin.57.1.43</idno>
		<idno type="PMID">17237035</idno>
		<ptr type="open-access" target="http://pdfs.semanticscholar.org/02e9/d19e2759b43b3d95bb3f5f5e7252784b9612.pdf" />
	</analytic>
	<monogr>
		<title level="j">CA: A Cancer Journal for Clinicians</title>
		<title level="j" type="abbrev">CA: A Cancer Journal for Clinicians</title>
		<idno type="ISSN">0007-9235</idno>
		<imprint>
			<biblScope unit="volume">57</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="43" to="66" />
			<date type="published" when="2007-01-01" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b58">
	<analytic>
		<title level="a" type="main">Cancer Statistics, 2010</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Jemal</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Siegel</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><surname>Ward</surname></persName>
		</author>
		<idno type="DOI">10.3322/caac.20073</idno>
		<idno type="PMID">20610543</idno>
		<ptr type="open-access" target="http://pdfs.semanticscholar.org/992b/a166b4f49e8818c83e55ba5e9abec6c00f15.pdf" />
		<ptr target="http://dx.doi.org/10.3322/caac.20073" />
	</analytic>
	<monogr>
		<title level="j">CA: A Cancer Journal for Clinicians</title>
		<title level="j" type="abbrev">CA: A Cancer Journal for Clinicians</title>
		<idno type="ISSN">0007-9235</idno>
		<imprint>
			<biblScope unit="volume">60</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="277" to="300" />
			<date type="published" when="2010-07-07" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b59">
	<analytic>
		<title level="a" type="main">The lung cancer stage page: there when you need it--staginglungcancer.org</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">W</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">M</forename><surname>Johnson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><forename type="middle">C</forename><surname>Detterbeck</surname></persName>
		</author>
		<idno type="PMID">22396557</idno>
	</analytic>
	<monogr>
		<title level="j">Chest</title>
		<imprint>
			<biblScope unit="volume">141</biblScope>
			<biblScope unit="page" from="581" to="587" />
			<date type="published" when="2012" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b60">
	<analytic>
		<title level="a" type="main">The Lung Cancer Stage Page</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Anthony</forename><forename type="middle">W</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kelsey</forename><forename type="middle">M</forename><surname>Johnson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Frank</forename><forename type="middle">C</forename><surname>Detterbeck</surname></persName>
		</author>
		<idno type="DOI">10.1378/chest.11-3192</idno>
		<idno type="PMID">22396557</idno>
		<ptr target="http://dx.doi.org/10.1378/chest.11-3192" />
	</analytic>
	<monogr>
		<title level="j">Chest</title>
		<title level="j" type="abbrev">Chest</title>
		<idno type="ISSN">0012-3692</idno>
		<imprint>
			<biblScope unit="volume">141</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="581" to="586" />
			<date type="published" when="2012-03" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b61">
	<analytic>
		<title level="a" type="main">Temporal Trends in the Management of Potentially Resectable Lung Cancer</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Farhood</forename><surname>Farjah</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Douglas</forename><forename type="middle">E</forename><surname>Wood</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">David</forename><surname>Yanez</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Rebecca</forename><forename type="middle">G</forename><surname>Symons</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Bahirathan</forename><surname>Krishnadasan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">David</forename><forename type="middle">R</forename><surname>Flum</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.athoracsur.2007.12.081</idno>
		<idno type="PMID">18498783</idno>
	</analytic>
	<monogr>
		<title level="j">The Annals of Thoracic Surgery</title>
		<title level="j" type="abbrev">The Annals of Thoracic Surgery</title>
		<idno type="ISSN">0003-4975</idno>
		<imprint>
			<biblScope unit="volume">85</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="1850" to="1856" />
			<date type="published" when="2008-06" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b62">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">Ann Thorac Surg</title>
		<imprint>
			<biblScope unit="volume">85</biblScope>
			<biblScope unit="page" from="1850" to="1855" />
			<date type="published" when="2008" />
		</imprint>
	</monogr>
	<note>discussion 1856</note>
</biblStruct>

<biblStruct xml:id="b63">
	<monogr>
		<title/>
		<idno type="DOI">10.1016/j.atho-racsur.2007.12.081</idno>
		<idno type="PMID">18498783</idno>
		<ptr target="http://dx.doi.org/10.1016/j.atho-racsur.2007.12.081" />
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b64">
	<monogr>
		<title level="m" type="main">Long-term benefit is observed in a phase III comparison of sequential vs concurrent chemo-radiation for patients with unresected stage III non small cell lung cancer</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><surname>Curran</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Scott</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Langer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Komaki</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">S</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Hauser</surname></persName>
		</author>
		<imprint/>
	</monogr>
	<note>RTOG 9410 [abstract</note>
</biblStruct>

<biblStruct xml:id="b65">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">Proc Am Soc Clin Oncol</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page">621</biblScope>
			<date type="published" when="2003" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b66">
	<analytic>
		<title level="a" type="main">Aberrant p53 expression predicts clinical resistance to cisplatin-based chemotherapy in locally advanced non-small cell lung cancer</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">V</forename><surname>Rusch</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Klimstra</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><surname>Venkatraman</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Oliver</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><surname>Martini</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Gralla</surname></persName>
		</author>
		<idno type="PMID">7585548</idno>
	</analytic>
	<monogr>
		<title level="j">Cancer Res</title>
		<imprint>
			<biblScope unit="volume">55</biblScope>
			<biblScope unit="page" from="5038" to="5080" />
			<date type="published" when="1995" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b67">
	<analytic>
		<title level="a" type="main">The tp53 genotype but not immunohistochemical result is predictive of response to cisplatin-based neoadjuvant therapy in stage III non–small cell lung cancer</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Daniela</forename><surname>Kandioler-Eckersberger</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Kappel</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Mittlböck</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Dekan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Ludwig</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><surname>Janschek</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Pirker</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><surname>Wolner</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><surname>Eckersberger</surname></persName>
		</author>
		<idno type="DOI">10.1016/s0022-5223(99)70295-3</idno>
		<idno type="PMID">10096970</idno>
		<idno type="PII">S0022-5223(99)70295-3</idno>
		<idno type="ark">ark:/67375/6H6-XXCG9DG5-K</idno>
		<idno type="istexId">DD075FA429E9579EF8F44294D6FCA8CE7B2FBECD</idno>
	</analytic>
	<monogr>
		<title level="j">The Journal of Thoracic and Cardiovascular Surgery</title>
		<title level="j" type="abbrev">The Journal of Thoracic and Cardiovascular Surgery</title>
		<idno type="ISSN">0022-5223</idno>
		<imprint>
			<biblScope unit="volume">117</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="744" to="750" />
			<date type="published" when="1999-04" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b68">
	<monogr>
		<title/>
		<idno type="DOI">10.1016/S0022-5223(99</idno>
		<ptr target="http://dx.doi.org/10.1016/S0022-5223(99" />
		<imprint>
			<biblScope unit="page" from="70295" to="70298" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b69">
	<analytic>
		<title level="a" type="main">Immune infiltration in human tumors: a prognostic factor that should not be ignored</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><surname>Pagès</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Galon</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M-C</forename><surname>Dieu-Nosjean</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><surname>Tartour</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Sautès-Fridman</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W-H</forename><surname>Fridman</surname></persName>
		</author>
		<idno type="DOI">10.1038/onc.2009.416</idno>
		<idno type="PMID">19946335</idno>
		<ptr type="open-access" target="https://www.nature.com/articles/onc2009416.pdf" />
		<ptr target="http://dx.doi.org/10.1038/onc.2009.416" />
	</analytic>
	<monogr>
		<title level="j">Oncogene</title>
		<title level="j" type="abbrev">Oncogene</title>
		<idno type="ISSN">0950-9232</idno>
		<idno type="ISSNe">1476-5594</idno>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="1093" to="1102" />
			<date type="published" when="2009-11-30" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b70">
	<analytic>
		<title level="a" type="main">Expression of TRAIL and TRAIL death receptors in stage III non-small cell lung cancer tumors</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Dcj</forename><surname>Spierings</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ege</forename><surname>De Vries</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><surname>Timens</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hjm</forename><surname>Groen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><forename type="middle">M</forename><surname>Boezen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>De Jong</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Cancer Res</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="3397" to="405" />
			<date type="published" when="2003" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b71">
	<analytic>
		<title level="a" type="main">Increased serum kynurenine/tryptophan ratio correlates with disease progression in lung cancer</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yuzo</forename><surname>Suzuki</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Takafumi</forename><surname>Suda</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kazuki</forename><surname>Furuhashi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Masako</forename><surname>Suzuki</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Michio</forename><surname>Fujie</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Dai</forename><surname>Hahimoto</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yutaro</forename><surname>Nakamura</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Naoki</forename><surname>Inui</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hirotoshi</forename><surname>Nakamura</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kingo</forename><surname>Chida</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.lungcan.2009.05.001</idno>
		<idno type="PMID">19487045</idno>
	</analytic>
	<monogr>
		<title level="j">Lung Cancer</title>
		<title level="j" type="abbrev">Lung Cancer</title>
		<idno type="ISSN">0169-5002</idno>
		<imprint>
			<biblScope unit="volume">67</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="361" to="365" />
			<date type="published" when="2010-03" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b72">
	<monogr>
		<title/>
		<idno type="DOI">10.1016/j.lung-can.2009.05.001</idno>
		<idno type="PMID">19487045</idno>
		<ptr target="http://dx.doi.org/10.1016/j.lung-can.2009.05.001" />
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b73">
	<analytic>
		<title level="a" type="main">Increased tryptophan degradation in patients with bronchus carcinoma</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">B</forename><surname>Engin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Ozkan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Fuchs</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Yardim-Akaydin</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1365-2354.2009.01122.x</idno>
		<idno type="PMID">19702697</idno>
		<idno type="ark">ark:/67375/WNG-6GSDLND6-X</idno>
		<idno type="istexId">E6162736B2FE04E90DD4F5C0F4ED433EAE850120</idno>
		<ptr target="http://dx.doi.org/10.1111/j.1365-2354.2009.01122.x" />
	</analytic>
	<monogr>
		<title level="j">European Journal of Cancer Care</title>
		<idno type="ISSN">0961-5423</idno>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="803" to="808" />
			<date type="published" when="2009-08-20" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b74">
	<analytic>
		<title level="a" type="main">Bin1 Ablation Increases Susceptibility to Cancer during Aging, Particularly Lung Cancer</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">Y</forename><surname>Chang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Boulden</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">B</forename><surname>Katz</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><forename type="middle">J</forename><surname>Meyer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">P</forename><surname>Soler</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">J</forename><surname>Muller</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><forename type="middle">C</forename><surname>Prendergast</surname></persName>
		</author>
		<idno type="DOI">10.1158/0008-5472.can-07-1100</idno>
		<idno type="PMID">17699764</idno>
		<ptr type="open-access" target="https://cancerres.aacrjournals.org/content/canres/67/16/7605.full.pdf" />
		<ptr target="http://dx.doi.org/10.1158/0008-5472.CAN-07-1100" />
	</analytic>
	<monogr>
		<title level="j">Cancer Research</title>
		<title level="j" type="abbrev">Cancer Research</title>
		<idno type="ISSN">0008-5472</idno>
		<idno type="ISSNe">1538-7445</idno>
		<imprint>
			<biblScope unit="volume">67</biblScope>
			<biblScope unit="issue">16</biblScope>
			<biblScope unit="page" from="7605" to="7612" />
			<date type="published" when="2007-08-08" />
			<publisher>American Association for Cancer Research (AACR)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b75">
	<analytic>
		<title level="a" type="main">Immunoactivative role of indoleamine 2,3-dioxygenase in human hepatocellular carcinoma</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tetsuya</forename><surname>Ishio</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Shigeru</forename><surname>Goto</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kouichirou</forename><surname>Tahara</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Shigenobu</forename><surname>Tone</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Katsunori</forename><surname>Kawano</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Seigo</forename><surname>Kitano</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1440-1746.2003.03259.x</idno>
		<idno type="PMID">14748880</idno>
		<idno type="ark">ark:/67375/WNG-K94L5B9R-W</idno>
		<idno type="istexId">4B1AEC8D1AEC3F29D29C334289FFBE44FD305B1C</idno>
		<ptr target="http://dx.doi.org/10.1111/j.1440-1746.2003.03259.x" />
	</analytic>
	<monogr>
		<title level="j">Journal of Gastroenterology and Hepatology</title>
		<title level="j" type="abbrev">J Gastroenterol Hepatol</title>
		<idno type="ISSN">0815-9319</idno>
		<idno type="ISSNe">1440-1746</idno>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="319" to="326" />
			<date type="published" when="2004-03" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b76">
	<analytic>
		<title level="a" type="main">The paradoxical patterns of expression of indoleamine 2,3-dioxygenase in colon cancer</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yan-Fang</forename><surname>Gao</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Rui-Qing</forename><surname>Peng</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jiang</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ya</forename><surname>Ding</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Xing</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Xiao-Jun</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Zhi-Zhong</forename><surname>Pan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">De-Sen</forename><surname>Wan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yi-Xin</forename><surname>Zeng</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Xiao-Shi</forename><surname>Zhang</surname></persName>
		</author>
		<idno type="DOI">10.1186/1479-5876-7-71</idno>
		<idno type="PMID">19695096</idno>
		<idno type="PMCID">PMC2736158</idno>
		<ptr type="open-access" target="https://translational-medicine.biomedcentral.com/track/pdf/10.1186/1479-5876-7-71" />
		<ptr target="http://dx.doi.org/10.1186/1479-5876-7-71" />
	</analytic>
	<monogr>
		<title level="j">Journal of Translational Medicine</title>
		<title level="j" type="abbrev">Journal of Translational Medicine</title>
		<idno type="ISSN">1479-5876</idno>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">71</biblScope>
			<date type="published" when="2009" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b77">
	<analytic>
		<title level="a" type="main">Indoleamine 2,3-dioxygenase in tumor tissue indicates prognosis in patients with diffuse large B-cell lymphoma treated with R-CHOP</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Soranobu</forename><surname>Ninomiya</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Takeshi</forename><surname>Hara</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hisashi</forename><surname>Tsurumi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Masato</forename><surname>Hoshi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Nobuhiro</forename><surname>Kanemura</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Naoe</forename><surname>Goto</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Senji</forename><surname>Kasahara</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Masahito</forename><surname>Shimizu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hiroyasu</forename><surname>Ito</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kuniaki</forename><surname>Saito</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yoshinobu</forename><surname>Hirose</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tetsuya</forename><surname>Yamada</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Takeshi</forename><surname>Takahashi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mitsuru</forename><surname>Seishima</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tsuyoshi</forename><surname>Takami</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hisataka</forename><surname>Moriwaki</surname></persName>
		</author>
		<idno type="DOI">10.1007/s00277-010-1093-z</idno>
		<idno type="PMID">20938662</idno>
		<idno type="ark">ark:/67375/VQC-F21K1NJT-T</idno>
		<idno type="istexId">D7E9AC702B7816C757A1DC6DEFE2D0C7CFE5111D</idno>
		<ptr target="http://dx.doi.org/10.1007/s00277-010-1093-z" />
	</analytic>
	<monogr>
		<title level="j">Annals of Hematology</title>
		<title level="j" type="abbrev">Ann Hematol</title>
		<idno type="ISSN">0939-5555</idno>
		<idno type="ISSNe">1432-0584</idno>
		<imprint>
			<biblScope unit="volume">90</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="409" to="416" />
			<date type="published" when="2010-10-12" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b78">
	<analytic>
		<title level="a" type="main">Inverse Correlation between Tumoral Indoleamine 2,3-Dioxygenase Expression and Tumor-Infiltrating Lymphocytes in Endometrial Cancer: Its Association with Disease Progression and Survival</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Ino</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><surname>Yamamoto</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Shibata</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Kajiyama</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><surname>Yoshida</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Terauchi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Nawa</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Nagasaka</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">O</forename><surname>Takikawa</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><surname>Kikkawa</surname></persName>
		</author>
		<idno type="DOI">10.1158/1078-0432.ccr-07-4144</idno>
		<idno type="PMID">18413819</idno>
		<ptr type="open-access" target="http://clincancerres.aacrjournals.org/content/14/8/2310.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Clinical Cancer Research</title>
		<title level="j" type="abbrev">Clinical Cancer Research</title>
		<idno type="ISSN">1078-0432</idno>
		<idno type="ISSNe">1557-3265</idno>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="2310" to="2317" />
			<date type="published" when="2008-03-27" />
			<publisher>American Association for Cancer Research (AACR)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b79">
	<analytic>
		<title level="a" type="main">Inverse Correlation between Tumoral Indoleamine 2,3-Dioxygenase Expression and Tumor-Infiltrating Lymphocytes in Endometrial Cancer: Its Association with Disease Progression and Survival</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Ino</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><surname>Yamamoto</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Shibata</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Kajiyama</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><surname>Yoshida</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Terauchi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Nawa</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Nagasaka</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">O</forename><surname>Takikawa</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><surname>Kikkawa</surname></persName>
		</author>
		<idno type="DOI">10.1158/1078-0432.ccr-07-4144</idno>
		<idno type="PMID">18413819</idno>
		<ptr type="open-access" target="http://clincancerres.aacrjournals.org/content/14/8/2310.full.pdf" />
		<ptr target="http://dx.doi.org/10.1158/1078-0432.CCR-07-4144" />
	</analytic>
	<monogr>
		<title level="j">Clinical Cancer Research</title>
		<title level="j" type="abbrev">Clinical Cancer Research</title>
		<idno type="ISSN">1078-0432</idno>
		<idno type="ISSNe">1557-3265</idno>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="2310" to="2317" />
			<date type="published" when="2008-03-27" />
			<publisher>American Association for Cancer Research (AACR)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b80">
	<analytic>
		<title level="a" type="main">Indoleamine 2,3-dioxygenase expression predicts impaired survival of invasive cervical cancer patients treated with radical hysterectomy</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tomoko</forename><surname>Inaba</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kazuhiko</forename><surname>Ino</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hiroaki</forename><surname>Kajiyama</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kiyosumi</forename><surname>Shibata</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Eiko</forename><surname>Yamamoto</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Shinji</forename><surname>Kondo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tomokazu</forename><surname>Umezu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Akihiro</forename><surname>Nawa</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Osamu</forename><surname>Takikawa</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Fumitaka</forename><surname>Kikkawa</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.ygyno.2010.02.028</idno>
		<idno type="PMID">20350764</idno>
		<ptr target="http://dx.doi.org/10.1016/j.ygyno.2010.02.028" />
	</analytic>
	<monogr>
		<title level="j">Gynecologic Oncology</title>
		<title level="j" type="abbrev">Gynecologic Oncology</title>
		<idno type="ISSN">0090-8258</idno>
		<imprint>
			<biblScope unit="volume">117</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="423" to="428" />
			<date type="published" when="2010-06" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b81">
	<analytic>
		<title level="a" type="main">Indoleamine 2,3-dioxygenase, a new prognostic marker in sentinel lymph nodes of melanoma patients</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Reinhart</forename><surname>Speeckaert</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Karim</forename><surname>Vermaelen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Nanja</forename><surname>Van Geel</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Philippe</forename><surname>Autier</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jo</forename><surname>Lambert</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Marc</forename><surname>Haspeslagh</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mireille</forename><surname>Van Gele</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kris</forename><surname>Thielemans</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Bart</forename><surname>Neyns</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Nathalie</forename><surname>Roche</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Natacha</forename><surname>Verbeke</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Philippe</forename><surname>Deron</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Marijn</forename><surname>Speeckaert</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Lieve</forename><surname>Brochez</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.ejca.2011.09.007</idno>
		<idno type="PMID">22033321</idno>
		<ptr target="http://dx.doi.org/10.1016/j.ejca.2011.09.007" />
	</analytic>
	<monogr>
		<title level="j">European Journal of Cancer</title>
		<title level="j" type="abbrev">European Journal of Cancer</title>
		<idno type="ISSN">0959-8049</idno>
		<imprint>
			<biblScope unit="volume">48</biblScope>
			<biblScope unit="issue">13</biblScope>
			<biblScope unit="page" from="2004" to="2011" />
			<date type="published" when="2012-09" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b82">
	<analytic>
		<title level="a" type="main">Prognostic value of indoleamine 2,3-dioxygenase expression in high grade osteosarcoma</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hiroshi</forename><surname>Urakawa</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yoshihiro</forename><surname>Nishida</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hiroatsu</forename><surname>Nakashima</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yoshie</forename><surname>Shimoyama</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Shigeo</forename><surname>Nakamura</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Naoki</forename><surname>Ishiguro</surname></persName>
		</author>
		<idno type="DOI">10.1007/s10585-009-9290-7</idno>
		<idno type="PMID">19802733</idno>
		<idno type="ark">ark:/67375/VQC-0D4J8RW5-7</idno>
		<idno type="istexId">43144DC38B8664FDB5110C56BF5044D07A7BB60E</idno>
	</analytic>
	<monogr>
		<title level="j">Clinical &amp; Experimental Metastasis</title>
		<title level="j" type="abbrev">Clin Exp Metastasis</title>
		<idno type="ISSN">0262-0898</idno>
		<idno type="ISSNe">1573-7276</idno>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="1005" to="1012" />
			<date type="published" when="2009-10-06" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b83">
	<analytic>
		<title level="a" type="main">Prognostic value of indoleamine 2,3-dioxygenase expression in high grade osteosarcoma</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hiroshi</forename><surname>Urakawa</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yoshihiro</forename><surname>Nishida</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hiroatsu</forename><surname>Nakashima</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yoshie</forename><surname>Shimoyama</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Shigeo</forename><surname>Nakamura</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Naoki</forename><surname>Ishiguro</surname></persName>
		</author>
		<idno type="DOI">10.1007/s10585-009-9290-7</idno>
		<idno type="PMID">19802733</idno>
		<idno type="ark">ark:/67375/VQC-0D4J8RW5-7</idno>
		<idno type="istexId">43144DC38B8664FDB5110C56BF5044D07A7BB60E</idno>
		<ptr target="http://dx.doi.org/10.1007/s10585-009-9290-7" />
	</analytic>
	<monogr>
		<title level="j">Clinical &amp; Experimental Metastasis</title>
		<title level="j" type="abbrev">Clin Exp Metastasis</title>
		<idno type="ISSN">0262-0898</idno>
		<idno type="ISSNe">1573-7276</idno>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="1005" to="1012" />
			<date type="published" when="2009-10-06" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b84">
	<analytic>
		<title level="a" type="main">Uveal melanoma expression of indoleamine 2,3-deoxygenase: Establishment of an immune privileged environment by tryptophan depletion</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Peter</forename><forename type="middle">W</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jessamee</forename><forename type="middle">K</forename><surname>Mellon</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Elizabeth</forename><surname>Mayhew</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Shixuan</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yu</forename><forename type="middle">Guang</forename><surname>He</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Nick</forename><surname>Hogan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jerry</forename><forename type="middle">Y</forename><surname>Niederkorn</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.exer.2007.07.014</idno>
		<idno type="PMID">17870068</idno>
		<idno type="PMCID">PMC2695208</idno>
		<ptr type="open-access" target="http://europepmc.org/articles/pmc2695208?pdf=render" />
		<ptr target="http://dx.doi.org/10.1016/j.exer.2007.07.014" />
	</analytic>
	<monogr>
		<title level="j">Experimental Eye Research</title>
		<title level="j" type="abbrev">Experimental Eye Research</title>
		<idno type="ISSN">0014-4835</idno>
		<imprint>
			<biblScope unit="volume">85</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="617" to="625" />
			<date type="published" when="2007-11" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b85">
	<analytic>
		<title level="a" type="main">FOXP3+ Regulatory T Cells and Tumoral Indoleamine 2,3-Dioxygenase Expression Predicts the Carcinogenesis of Intraductal Papillary Mucinous Neoplasms of the Pancreas</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Noritoshi</forename><surname>Kobayashi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kensuke</forename><surname>Kubota</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Shingo</forename><surname>Kato</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Seitaro</forename><surname>Watanabe</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Takeshi</forename><surname>Shimamura</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hiroyuki</forename><surname>Kirikoshi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Satoru</forename><surname>Saito</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Michio</forename><surname>Ueda</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Itaru</forename><surname>Endo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yoshiaki</forename><surname>Lnayama</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Shin</forename><surname>Maeda</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Atsushi</forename><surname>Nakajima</surname></persName>
		</author>
		<idno type="DOI">10.1159/000308966</idno>
		<idno type="PMID">21051918</idno>
		<ptr target="http://dx.doi.org/10.1159/000308966" />
	</analytic>
	<monogr>
		<title level="j">Pancreatology</title>
		<title level="j" type="abbrev">Pancreatology</title>
		<idno type="ISSN">1424-3903</idno>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="631" to="640" />
			<date type="published" when="2010-12" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b86">
	<analytic>
		<title level="a" type="main">Prognostic role of indoleamine 2,3-dioxygenase in endometrial carcinoma</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Renske</forename><forename type="middle">A</forename><surname>De Jong</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ido</forename><forename type="middle">P</forename><surname>Kema</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Annemarie</forename><surname>Boerma</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><forename type="middle">Marike</forename><surname>Boezen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Johannes</forename><forename type="middle">J L Van</forename><surname>Der Want</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Marloes</forename><forename type="middle">J M</forename><surname>Gooden</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Harry</forename><surname>Hollema</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hans</forename><forename type="middle">W</forename><surname>Nijman</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.ygyno.2012.05.034</idno>
		<idno type="PMID">22668882</idno>
	</analytic>
	<monogr>
		<title level="j">Gynecologic Oncology</title>
		<title level="j" type="abbrev">Gynecologic Oncology</title>
		<idno type="ISSN">0090-8258</idno>
		<imprint>
			<biblScope unit="volume">126</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="474" to="480" />
			<date type="published" when="2012-09" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b87">
	<analytic>
		<title level="a" type="main">Prognostic role of indoleamine 2,3-dioxygenase in endometrial carcinoma</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Renske</forename><forename type="middle">A</forename><surname>De Jong</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ido</forename><forename type="middle">P</forename><surname>Kema</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Annemarie</forename><surname>Boerma</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><forename type="middle">Marike</forename><surname>Boezen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Johannes</forename><forename type="middle">J L Van</forename><surname>Der Want</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Marloes</forename><forename type="middle">J M</forename><surname>Gooden</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Harry</forename><surname>Hollema</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hans</forename><forename type="middle">W</forename><surname>Nijman</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.ygyno.2012.05.034</idno>
		<idno type="PMID">22668882</idno>
		<ptr target="http://dx.doi.org/10.1016/j.ygyno.2012.05.034" />
	</analytic>
	<monogr>
		<title level="j">Gynecologic Oncology</title>
		<title level="j" type="abbrev">Gynecologic Oncology</title>
		<idno type="ISSN">0090-8258</idno>
		<imprint>
			<biblScope unit="volume">126</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="474" to="480" />
			<date type="published" when="2012-09" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b88">
	<analytic>
		<title level="a" type="main">Status of cellular immunity lacks prognostic significance in vulvar squamous carcinoma</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">A</forename><surname>De Jong</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><forename type="middle">L</forename><surname>Toppen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">A</forename><surname>Ten Hoor</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><forename type="middle">M</forename><surname>Boezen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">I</forename><forename type="middle">P</forename><surname>Kema</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Hollema</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><forename type="middle">W</forename><surname>Nijman</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.ygyno.2011.12.416</idno>
		<idno type="PMID">22155674</idno>
		<ptr type="open-access" target="https://pure.rug.nl/ws/files/6776337/de_Jong_2012_Gynecol_Oncol_2.pdf" />
		<ptr target="http://dx.doi.org/10.1016/j.ygyno.2011.12.416" />
	</analytic>
	<monogr>
		<title level="j">Gynecologic Oncology</title>
		<title level="j" type="abbrev">Gynecologic Oncology</title>
		<idno type="ISSN">0090-8258</idno>
		<imprint>
			<biblScope unit="volume">125</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="186" to="193" />
			<date type="published" when="2012-04" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b89">
	<analytic>
		<title level="a" type="main">Expression of indoleamine 2,3-dioxygenase in metastatic malignant melanoma recruits regulatory T cells to avoid immune detection and affects survival</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jonathan</forename><forename type="middle">R</forename><surname>Brody</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Christina</forename><forename type="middle">L</forename><surname>Costantino</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Adam</forename><forename type="middle">C</forename><surname>Berger</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Takami</forename><surname>Sato</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Michael</forename><forename type="middle">P</forename><surname>Lisanti</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Charles</forename><forename type="middle">J</forename><surname>Yeo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Robert</forename><forename type="middle">V</forename><surname>Emmons</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Agnieszka</forename><forename type="middle">K</forename><surname>Witkiewicz</surname></persName>
		</author>
		<idno type="DOI">10.4161/cc.8.12.8745</idno>
		<idno type="PMID">19448397</idno>
		<ptr type="open-access" target="https://www.tandfonline.com/doi/pdf/10.4161/cc.8.12.8745?needAccess=true" />
	</analytic>
	<monogr>
		<title level="j">Cell Cycle</title>
		<title level="j" type="abbrev">Cell Cycle</title>
		<idno type="ISSN">1538-4101</idno>
		<idno type="ISSNe">1551-4005</idno>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="1930" to="1934" />
			<date type="published" when="2009-06-15" />
			<publisher>Informa UK Limited</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b90">
	<analytic>
		<title level="a" type="main">Expression of indoleamine 2,3-dioxygenase in metastatic malignant melanoma recruits regulatory T cells to avoid immune detection and affects survival</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jonathan</forename><forename type="middle">R</forename><surname>Brody</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Christina</forename><forename type="middle">L</forename><surname>Costantino</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Adam</forename><forename type="middle">C</forename><surname>Berger</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Takami</forename><surname>Sato</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Michael</forename><forename type="middle">P</forename><surname>Lisanti</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Charles</forename><forename type="middle">J</forename><surname>Yeo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Robert</forename><forename type="middle">V</forename><surname>Emmons</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Agnieszka</forename><forename type="middle">K</forename><surname>Witkiewicz</surname></persName>
		</author>
		<idno type="DOI">10.4161/cc.8.12.8745</idno>
		<idno type="PMID">19448397</idno>
		<ptr type="open-access" target="https://www.tandfonline.com/doi/pdf/10.4161/cc.8.12.8745?needAccess=true" />
		<ptr target="http://dx.doi.org/10.4161/cc.8.12.8745" />
	</analytic>
	<monogr>
		<title level="j">Cell Cycle</title>
		<title level="j" type="abbrev">Cell Cycle</title>
		<idno type="ISSN">1538-4101</idno>
		<idno type="ISSNe">1551-4005</idno>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="1930" to="1934" />
			<date type="published" when="2009-06-15" />
			<publisher>Informa UK Limited</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b91">
	<analytic>
		<title level="a" type="main">Pattern of Recruitment of Immunoregulatory Antigen-Presenting Cells in Malignant Melanoma</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jeffrey</forename><forename type="middle">R</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Rory</forename><forename type="middle">R</forename><surname>Dalton</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jane</forename><forename type="middle">L</forename><surname>Messina</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Madhav</forename><forename type="middle">D</forename><surname>Sharma</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">David</forename><forename type="middle">M</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Russell</forename><forename type="middle">E</forename><surname>Burgess</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Fermina</forename><surname>Mazzella</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Scott</forename><forename type="middle">J</forename><surname>Antonia</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Andrew</forename><forename type="middle">L</forename><surname>Mellor</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">David</forename><forename type="middle">H</forename><surname>Munn</surname></persName>
		</author>
		<idno type="DOI">10.1097/01.lab.0000090158.68852.d1</idno>
		<idno type="PMID">14563947</idno>
		<ptr type="open-access" target="https://www.nature.com/articles/3780736.pdf" />
		<ptr target="http://dx.doi.org/10.1097/01.LAB.0000090158.68852.D1" />
	</analytic>
	<monogr>
		<title level="j">Laboratory Investigation</title>
		<title level="j" type="abbrev">Lab Invest</title>
		<idno type="ISSN">0023-6837</idno>
		<idno type="ISSNe">1530-0307</idno>
		<imprint>
			<biblScope unit="volume">83</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="1457" to="1466" />
			<date type="published" when="2003-10" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b92">
	<analytic>
		<title level="a" type="main">Expression of indoleamine 2, 3-dioxygenase and the recruitment of Foxp3-expressing regulatory T cells in the development and progression of uterine cervical cancer</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Takafumi</forename><surname>Nakamura</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tomoko</forename><surname>Shima</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ai</forename><surname>Saeki</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Takao</forename><surname>Hidaka</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Akitoshi</forename><surname>Nakashima</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Osamu</forename><surname>Takikawa</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Shigeru</forename><surname>Saito</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1349-7006.2007.00470.x</idno>
		<idno type="PMID">17433037</idno>
	</analytic>
	<monogr>
		<title level="j">Cancer Science</title>
		<title level="j" type="abbrev">Cancer Science</title>
		<idno type="ISSN">1347-9032</idno>
		<idno type="ISSNe">1349-7006</idno>
		<imprint>
			<biblScope unit="volume">98</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="874" to="881" />
			<date type="published" when="2007-06" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b93">
	<analytic>
		<title level="a" type="main">Expression of indoleamine 2, 3-dioxygenase and the recruitment of Foxp3-expressing regulatory T cells in the development and progression of uterine cervical cancer</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Takafumi</forename><surname>Nakamura</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tomoko</forename><surname>Shima</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ai</forename><surname>Saeki</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Takao</forename><surname>Hidaka</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Akitoshi</forename><surname>Nakashima</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Osamu</forename><surname>Takikawa</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Shigeru</forename><surname>Saito</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1349-7006.2007.00470.x</idno>
		<idno type="PMID">17433037</idno>
		<ptr target="http://dx.doi.org/10.1111/j.1349-7006.2007.00470.x" />
	</analytic>
	<monogr>
		<title level="j">Cancer Science</title>
		<title level="j" type="abbrev">Cancer Science</title>
		<idno type="ISSN">1347-9032</idno>
		<idno type="ISSNe">1349-7006</idno>
		<imprint>
			<biblScope unit="volume">98</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="874" to="881" />
			<date type="published" when="2007-06" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b94">
	<analytic>
		<title level="a" type="main">Increased synthesis of indoleamine-2,3-dioxygenase protein is positively associated with impaired survival in patients with serous-type, but not with other types of, ovarian cancer</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Miho</forename><surname>Takao</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Aikou</forename><surname>Okamoto</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Takashi</forename><surname>Nikaido</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mitsuyoshi</forename><surname>Urashima</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Satoshi</forename><surname>Takakura</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Misato</forename><surname>Saito</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Motoaki</forename><surname>Saito</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sanshiro</forename><surname>Okamoto</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Osamu</forename><surname>Takikawa</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hiroshi</forename><surname>Sasaki</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Makoto</forename><surname>Yasuda</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kazunori</forename><surname>Ochiai</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tadao</forename><surname>Tanaka</surname></persName>
		</author>
		<idno type="DOI">10.3892/or.17.6.1333</idno>
		<idno type="PMID">17487387</idno>
		<ptr type="open-access" target="http://www.spandidos-publications.com/or/17/6/1333/download" />
	</analytic>
	<monogr>
		<title level="j">Oncology Reports</title>
		<title level="j" type="abbrev">Oncol Rep</title>
		<idno type="ISSN">1021-335X</idno>
		<idno type="ISSNe">1791-2431</idno>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="1333" to="1342" />
			<date type="published" when="2007-06-01" />
			<publisher>Spandidos Publications</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b95">
	<analytic>
		<title level="a" type="main">High expression of indoleamine 2,3-dioxygenase in the tumour is associated with medullary features and favourable outcome in basal-like breast carcinoma</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jocelyne</forename><surname>Jacquemier</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">François</forename><surname>Bertucci</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Pascal</forename><surname>Finetti</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Benjamin</forename><surname>Esterni</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Emmanuelle</forename><surname>Charafe-Jauffret</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Marie-Laure</forename><surname>Thibult</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Gilles</forename><surname>Houvenaeghel</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Benoit</forename><surname>Van Den Eynde</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Daniel</forename><surname>Birnbaum</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Daniel</forename><surname>Olive</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Luc</forename><surname>Xerri</surname></persName>
		</author>
		<idno type="DOI">10.1002/ijc.25979</idno>
		<idno type="PMID">21328335</idno>
		<idno type="ark">ark:/67375/WNG-8W230M4Q-G</idno>
		<idno type="istexId">69F7E1751F65A29D7E12294405A7C180C983BF7F</idno>
		<ptr target="http://dx.doi.org/10.1002/ijc.25979" />
	</analytic>
	<monogr>
		<title level="j">International Journal of Cancer</title>
		<title level="j" type="abbrev">Int. J. Cancer</title>
		<idno type="ISSN">0020-7136</idno>
		<imprint>
			<biblScope unit="volume">130</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="96" to="104" />
			<date type="published" when="2011-10-27" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b96">
	<analytic>
		<title level="a" type="main">Expression and prognostic impact of indoleamine 2,3-dioxygenase in oral squamous cell carcinomas</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Klaus</forename><surname>Laimer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Birgit</forename><surname>Troester</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Frank</forename><surname>Kloss</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Georg</forename><surname>Schafer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Peter</forename><surname>Obrist</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Alexander</forename><surname>Perathoner</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Johannes</forename><surname>Laimer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Gerald</forename><surname>Brandacher</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Michael</forename><surname>Rasse</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Raimund</forename><surname>Margreiter</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Albert</forename><surname>Amberger</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.oraloncology.2011.03.007</idno>
		<idno type="PMID">21440489</idno>
		<ptr target="http://dx.doi.org/10.1016/j.oraloncology.2011.03.007" />
	</analytic>
	<monogr>
		<title level="j">Oral Oncology</title>
		<title level="j" type="abbrev">Oral Oncology</title>
		<idno type="ISSN">1368-8375</idno>
		<imprint>
			<biblScope unit="volume">47</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="352" to="357" />
			<date type="published" when="2011-05" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b97">
	<analytic>
		<title level="a" type="main">Study of indoleamine 2,3-dioxygenase expression in patients with breast cancer</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Sakurai</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Amano</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Enomoto</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Kashio</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Saito</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Sakamoto</surname></persName>
		</author>
		<idno type="PMID">16315864</idno>
	</analytic>
	<monogr>
		<title level="j">Gan To Kagaku Ryoho</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="page" from="1546" to="1555" />
			<date type="published" when="2005" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b98">
	<analytic>
		<title level="a" type="main">Prognostic Value of Indoleamine 2,3-Dioxygenase Expression in Colorectal Cancer: Effect on Tumor-Infiltrating T Cells</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Brandacher</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Perathoner</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Ladurner</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Schneeberger</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Obrist</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Winkler</surname></persName>
		</author>
		<idno type="DOI">10.1158/1078-0432.ccr-05-1966</idno>
		<idno type="PMID">16489067</idno>
		<ptr type="open-access" target="http://clincancerres.aacrjournals.org/content/12/4/1144.full.pdf" />
		<ptr target="http://dx.doi.org/10.1158/1078-0432.CCR-05-1966" />
	</analytic>
	<monogr>
		<title level="j">Clinical Cancer Research</title>
		<title level="j" type="abbrev">Clinical Cancer Research</title>
		<idno type="ISSN">1078-0432</idno>
		<idno type="ISSNe">1557-3265</idno>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="1144" to="1151" />
			<date type="published" when="2006-02-15" />
			<publisher>American Association for Cancer Research (AACR)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b99">
	<analytic>
		<title level="a" type="main">Clinicopathological significance of indoleamine 2,3-dioxygenase 1 expression in colorectal cancer</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Ferdinande</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Decaestecker</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Verset</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Mathieu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">X</forename><surname>Moles Lopez</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A-M</forename><surname>Negulescu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Van Maerken</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">I</forename><surname>Salmon</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">A</forename><surname>Cuvelier</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Demetter</surname></persName>
		</author>
		<idno type="DOI">10.1038/bjc.2011.513</idno>
		<idno type="PMID">22108515</idno>
		<idno type="PMCID">PMC3251860</idno>
		<ptr type="open-access" target="https://www.nature.com/articles/bjc2011513.pdf" />
		<ptr target="http://dx.doi.org/10.1038/bjc.2011.513" />
	</analytic>
	<monogr>
		<title level="j">British Journal of Cancer</title>
		<title level="j" type="abbrev">Br J Cancer</title>
		<idno type="ISSN">0007-0920</idno>
		<idno type="ISSNe">1532-1827</idno>
		<imprint>
			<biblScope unit="volume">106</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="141" to="147" />
			<date type="published" when="2011-11-22" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b100">
	<analytic>
		<title level="a" type="main">Indoleamine 2,3-dioxygenase is a novel prognostic indicator for endometrial cancer</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Ino</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><surname>Yoshida</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Kajiyama</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Shibata</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><surname>Yamamoto</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Kidokoro</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><surname>Takahashi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Terauchi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Nawa</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Nomura</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Nagasaka</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">O</forename><surname>Takikawa</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><surname>Kikkawa</surname></persName>
		</author>
		<idno type="DOI">10.1038/sj.bjc.6603477</idno>
		<idno type="PMID">17117179</idno>
		<idno type="PMCID">PMC2360726</idno>
		<ptr type="open-access" target="https://www.nature.com/articles/6603477.pdf" />
		<ptr target="http://dx.doi.org/10.1038/sj.bjc.6603477" />
	</analytic>
	<monogr>
		<title level="j">British Journal of Cancer</title>
		<title level="j" type="abbrev">Br J Cancer</title>
		<idno type="ISSN">0007-0920</idno>
		<idno type="ISSNe">1532-1827</idno>
		<imprint>
			<biblScope unit="volume">95</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="1555" to="1561" />
			<date type="published" when="2006-11-21" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b101">
	<analytic>
		<title level="a" type="main">Expression of Indoleamine 2,3-Dioxygenase in Metastatic Pancreatic Ductal Adenocarcinoma Recruits Regulatory T Cells to Avoid Immune Detection</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Agnes</forename><surname>Witkiewicz</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Timothy</forename><forename type="middle">K</forename><surname>Williams</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Joseph</forename><surname>Cozzitorto</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Brandice</forename><surname>Durkan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Shayna</forename><forename type="middle">L</forename><surname>Showalter</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Charles</forename><forename type="middle">J</forename><surname>Yeo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jonathan</forename><forename type="middle">R</forename><surname>Brody</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jamcollsurg.2007.12.014</idno>
		<idno type="PMID">18471709</idno>
		<ptr target="http://dx.doi.org/10.1016/j.jamcollsurg.2007.12.014" />
	</analytic>
	<monogr>
		<title level="j">Journal of the American College of Surgeons</title>
		<title level="j" type="abbrev">Journal of the American College of Surgeons</title>
		<idno type="ISSN">1072-7515</idno>
		<imprint>
			<biblScope unit="volume">206</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="849" to="854" />
			<date type="published" when="2008-05" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
	<note>discussion 854-6</note>
</biblStruct>

<biblStruct xml:id="b102">
	<analytic>
		<title level="a" type="main">Changes in the levels of thioredoxin and indoleamine-2,3-dioxygenase activity in plasma of patients with colorectal cancer treated with chemotherapy</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Monica</forename><surname>Cavia-Saiz</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Pilar</forename><surname>Muñiz</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Reyes</forename><surname>De Santiago</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Marta</forename><surname>Herreros-Villanueva</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Carlos</forename><surname>Garcia-Giron</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ana</forename><forename type="middle">Sofia</forename><surname>Lopez</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Maria</forename><forename type="middle">Jesus</forename><surname>Coma-Del Corral</surname></persName>
		</author>
		<idno type="DOI">10.1139/o11-077</idno>
		<idno type="PMID">22257103</idno>
		<ptr target="http://dx.doi.org/10.1139/o11-077" />
	</analytic>
	<monogr>
		<title level="j">Biochemistry and Cell Biology</title>
		<title level="j" type="abbrev">Biochem. Cell Biol.</title>
		<idno type="ISSN">0829-8211</idno>
		<idno type="ISSNe">1208-6002</idno>
		<imprint>
			<biblScope unit="volume">90</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="173" to="178" />
			<date type="published" when="2012-04" />
			<publisher>Canadian Science Publishing</publisher>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
